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ABSTRACT 
 
DEVELOPMENT AND VALIDATION OF A LIGHT WEIGHT, ENERGY 
DENSE, READY TO EAT (RTE) BAR 
 
Jacob Wilhelm-Maria Heick 
Providing additional calories in the form of an RTE bar to endurance athletes will 
increase performance and muscle re-synthesis, reduce muscle breakdown, and shorten 
recovery time. An RTE bar containing a blend of dairy proteins and carbohydrates will 
create a product with superior functionality, including bioactive and immunity enhancing 
properties from dairy derived ingredients. The protein will provide benefits in the form of 
easily digestible calories, essential amino acids and physical satiate.  
A formulation was developed and optimized, resulting in a final product that 
meets the required nutritional profile: 400kcal, 25grams protein per 100 gram serving 
size. The desired physical characteristics were achieved through processing by both 
conventional baking and freeze drying. The latter method improves the stability and 
functionality of the RTE bar.  
In order to meet the protein requirements of the RTE bar without compromising 
sensory properties, a unique protein source was developed. Using high concentrations of 
conventional protein sources like Whey Protein Concentrate (WPC) resulted in stale off-
flavors and unappealing textures. Milk Protein Precipitate (MPP) was developed for this 
formulation. MPP is a curd-like ingredient created through the combined heat and acid 
precipitation of dairy proteins. MPP can be used effectively in high concentrations 
provides a subtle dairy flavor. MPP delivers a balance of casein and whey, similar to that 
found in milk.  
The effectiveness of the RTE bar formulation as a post exercise recovery food 
was evaluated in a human studies experiment conducted on the Cal Poly campus. The 
human subjects study utilized 34 Cal Poly students in a single-blind cross-over design 
experiment. The study compared the effects of this high protein RTE bar against a 
calorically equal carbohydrate bar. The bars were administered after subjects completed 
the pre-assigned hikes on three consecutive days. Following the cross-over design, 
subjects received the alternate bar in the second period of the experiment. Several blood 
markers involved in metabolism and inflammation were measured before and after the 
two treatment periods. No blood marker showed a statistically significant difference 
between bars, but several trends were observed. Body weight and fat percent were also 
unaffected by bar composition.      
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1. INTRODUCTION  
The objective of this project was to develop a novel ready-to-eat (RTE) bar to 
positively influence exercise recovery through muscle re-growth. Detrimental health 
effects of over-exertion during physical activity include loss of lean muscle mass and 
inflammation. These symptoms are found among both combat military personnel and 
endurance athletes. This research aims to address these negative health impacts of over-
exertion through the development of a customized RTE bar, positively impact functional 
nutrition by tilting the daily energy balance and thereby reversing the negative effects of 
a caloric imbalance. In addition, the RTE bar was formulated to contain 50% of a 
Recommended Dietary Allowance (RDA) serving of complete protein. 
The nutritional profile of the RTE bar is modeled on a small meal or snack which 
will provide a balanced blend of macro and micro nutrients. The 100 gram bar provides 
400kcal and 25grams of protein in one serving. In order to meet these goals different 
protein sources were researched with a focus on the nutritional benefit of milk and dairy-
derived ingredients. In order to provide protein in a RTE bar at the stated high 
concentrations without compromising its sensory quality, a novel protein source was 
developed. This protein ingredient was shown to be an effective method of delivering the 
needed macronutrients.  
In order to validate the RTE formulation a human subjects study was conducted 
on the Cal Poly campus. The study utilized the high protein RTE bar and a control 
carbohydrate bar. The experiment was designed to mimic combat soldier activity in 
mountainous terrain. Several different response variables were taken during and after the 
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physical activity. The goal was to measure the influence of the exercise on concentration, 
inflammation, body composition, and peak power. Statistical analysis revealed no 
significant difference between the control carbohydrate and high protein RTE within the 
blood markers analyzed. However, the blood markers indicated that the exercises did 
induce inflammation in the subjects.  
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2. LITERATURE REVIEW  
Health Concerns  
Nutritional Concerns in the Military  
The military has long been concerned with the health and performance of its 
soldiers. This is witnessed by the special programs and institutions the military has 
dedicated to medical research. Examples of these include the Office of Naval Research, 
Army Research Institute of Environmental Medicine, US Army Natick Soldier Center, 
and the Institute of Medicine U.S. Army Medical Research and Nutrition Laboratory.  
The military’s main nutritional concern is sustaining and enhancing the physical and 
mental performance of soldier’s through diet (Anonymous 1994). During combat or 
regular training soldiers expend from (3109 kcal to 7131kcal) per day while consuming 
on average only 3000kcals per day (Tharion et al. 2005). There are many reasons for 
these extreme dietary deficiencies including: loss of appetite, lack of time and portability 
issues.  If not properly addressed, this energy imbalance can lead to loss in lean muscle 
mass, and impaired physical and cognitive performance (Marriott 1995). 
 A loss of fat free mass (FFM) can also be interpreted as a loss in lean muscle. 
This was demonstrated on Italian soldiers in a body composition and physical exercise 
study (Malavolti  et al. 2008). It was reported that the soldiers lost an average of 4.02kg 
+/- 1.42kg in FFM during the first three months of the experiment. This portion of the 
experiment contained increasingly strenuous exercises in the gym and in combat 
simulations, and was designed to represent ground combat with uncontrolled diets. The 
results of this experiment reflect the kind of situations that affect active duty soldiers 
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subjected to strenuous exercise. The effect of a negative energy balance has been 
investigated by numerous studies over the years. Observations include, but are not limited 
to: large losses in body mass, physical and mental fatigue, muscle soreness, weakness 
during recovery, impaired group function and  loss of motivation  (Montain and Young 
2003). While the extent of the physical or mental impairment fluctuated between the 
different tests, the general consensus is that the performance of the soldiers was 
negatively affected. Each research group applied its own levels of nutrients (fasting 
through 3600kcal per day) for varying periods (5 days - 6 months) as well as using 
different tests to register the response (time to complete run versus hand grip) (Montain 
and Young 2003).  
To avoid the effects of a negative energy balance, adequate calories must be 
consumed. To provide this nutrition in a way that is practical, as weight and space are 
constraints, small energy dense meals are seen as a solution.  This being the case, fat 
would seem to be the ideal supplement for a military ration. Fat provides 9kcal/gram 
versus 4kcal/gram for carbohydrates or protein (Montain and Young 2003). However, 
supplementing the diet with additional calories from fat does not lead to significantly 
greater performance or even increased lipid metabolism (Hoyt et al. 1991). A study by 
Hoyt et al. 1991 indicated that while fat contained in the supplement provides additional 
calories, it is not readily metabolized and does not reverse the effects of underfeeding.  
The Committee on Optimization of Nutrient Composition of Military Rations for Short-
Term, High-Stress Situations 2006 recommended a protein level of 1.2-1.5g per kg of 
body weight or 100-120g of protein per day. This is needed in order to maintain adequate 
serum levels while reducing net protein loss through sparing muscle protein breakdown. 
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This would be a large amount of protein to deliver in a single serving. So it was decided 
that a small energy dense ration, which could provide 25-30% of this amount would be 
ideal.      
Sarcopenia  
Sarcopenia is a muscle dilapidation disease that affects up to forty five percent of 
those over  the age of sixty five (Cribb 2006). While the mode of action of the disease is 
not well understood, the effects are being increasingly investigated. Sarcopenia is 
diagnosed as a loss of lean muscle mass with a corresponding increase in body fat (Evans 
2010). While sarcopenia refers directly to the loss of muscle in the elderly, treatment and 
research also investigate the young to better identify the causes of lean muscle loss. Lean 
muscle is the bulk tissue of the body that is responsible for movement and represents an 
energy source other than body fat or glycogen. Muscle is composed of protein and thus 
represents the body’s storage of amino acids that are utilized not only in metabolism but 
also numerous other physiological processes. Loss of skeletal muscle results from an 
imbalance between muscle protein synthesis and degradation (Evans 2010).  The cause of 
imbalance will vary for the specific demographic. For young persons it could be the 
result of over-exertion without adequate calories, while for older individuals it could be 
from a reduction in physical activity accompanying declining health and a poor diet. The 
mode of action for sarcopenia is the loss of the ability to convert available amino acids to 
glutamine, causing the body to increase anabolism of the liver to meet the demand of 
glutamine (Cribb 2006). For individuals consuming a hypocaloric diet, higher levels of 
dietary protein are required to reduce these detrimental effects (Lemon 1987). 
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 Muscle protein is the most important body protein for endurance athletes (Tipton 
and Wolfe 2004).   As the working site of movement, the muscle represents a major 
consumer of energy and the largest site of lipid oxidation and glucose metabolism (Cribb 
2006). In order to reverse damage or stimulate muscle anabolism, net protein synthesis 
must exceed protein breakdown.  In order to achieve this, a balance of macronutrient 
intake and resistance exercise must be introduced into the lifestyle (Cribb 2006). These 
two factors work synergistically providing a net gain in lean muscle mass that is greater 
than if each factor worked independently. During resistance exercise, the consumption of 
protein-rich dietary meals can be a major factor in maintaining or increaseing muscle 
mass (Phillips et al. 1998).  
Cachexia  
Cachexia is a complex metabolic condition that is associated with concurrent 
chronic diseases such as AIDS. Cachexia may affect any age group and is characterized 
by muscle wasting with or without body fat loss. Cachexia appears to selectively target 
actomyosin and thus heavily targets skeletal muscle (Evans et al. 2008). It appears 
cachexia can be reverted by therapies which reduce muscle inflammation and directly 
influence skeletal muscle growth in patients (Evans 2010).  
Gastrointestinal Health  
Diarrhea and other gastrointestinal problems have been associated with both 
military personnel and endurance athletes. The causes of these problems have been linked 
to stress, nutrition, and the physiological effect of exercise on the digestive system. One 
hypothesis is that during periods of extreme exertion blood flow is directed toward the 
active muscles, thus temporarily dehydrating the gut and increasing its sensitivity to 
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stress (Ha and Zemel 2003). Another theory relates the problems to fructose 
consumption. The Committee on Optimization of Nutrient Composition of Military 
Rations for Short-Term 2006 recommends limiting the amount of fructose in rations to 
below 25g. Fructose at higher levels than this may contribute to gastrointestinal problems 
(Anonymous 2006). High fructose corn syrup (HFCS) is a common ingredient in food 
formulations, particularly in bar and supplement products frequently used by athletes. 
The large quantities of fructose consumed directly from these products might contribute 
to the GI problems seen in these individuals.  
  Dairy products have historically been associated with gut health and research has 
identified whey protein as one contributing factor. Whey proteins provide 
glycomacropeptides that are potentially utilized as prebiotics, which stimulate the growth 
of probiotics. Glycomacropeptides may also activate cholecystokinin which has many 
physiological effects such as the regulation of food intake and the release of pancreatic 
enzymes (Dockray 2009). Milk also contains prebiotics and is commonly associated with 
Lactic acid bacteria, the major family of probiotics. Probiotics are associated with 
promoting gastrointestinal and immune system health as well as the synthesis of vitamins 
(Hazen 2009).  The benefits of probiotics result when viable organisms reach the small 
intestine in sufficient quantities thereby positively influencing the microflora of the small 
intestine. For this to occur, the organisms must be able to survive the initial processing of 
the food product and its eventual digestion in the mouth and stomach (Fernández et al. 
2003).   
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Protein And Sport Nutrition  
Protein Requirements for Athletes  
All biological proteins are assembled from twenty amino acids. They can be 
combined in numerous sequences to form the complex and diverse array of proteins seen 
in living systems. The defining characteristic of a protein is its vital amino nitrogen 
group. In addition,  proteins are the only macronutrient to contain nitrogen (Anonymous 
2005). Proteins and amino acids are vitally important components of the body because 
they function as cell membranes, hormones, enzymes, vitamin precursors and nucleic 
acids. With its diverse functions and interdependence, dietary protein is essential for 
health, reproduction, growth, and maintaining of homeostasis. Protein is a necessary 
component of the human diet. Currently the recommended daily allowance (RDA) is set 
at 0.8 grams protein/kg of body weight for the healthy average adult or 50grams protein 
per day (Anonymous 2005).  
There is a long-standing theory held by many athletes, coaches, supplement 
companies, and nutritionists that athletes need additional dietary protein. The logic being 
that proteins and amino acids are responsible for the synthesis and replacement of the 
structures associated with exercise and muscle building (Nemet and Eliakim 2007). 
Those who are more active would need more protein for fuel and rebuilding. Logic 
notwithstanding, there is little scientific proof that athletes require additional protein and 
some studies have even demonstrated that athletes require less protein (Phillips et al. 
2007), however the assumption remains.  The U.S and Canadian agencies responsible for 
the RDA have considered an increased consumption of protein of 1.2-1.4 grams 
protein/kg of body weight to be beneficial to endurance athletes (Tipton and Wolfe 
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1998).  However, they have not stated that athletes actually require this increase. 
Interestingly enough, most athletes already consume an excessive amount of protein, 
more than the RDA and even more than the increased RDA. Diet surveys on strength and 
power training athletes have estimated consumption levels as high as 2-3 grams 
protein/kg of body weight with endurance athletes consuming approximately 1.2-1.5 
grams protein/kg of body weight (Phillips et al. 2007).  
Protein Balance  
Energy balance is an important concept for individuals trying to modify body 
weight or composition.  This refers to the difference between calories from food 
consumed (input) and the calories expended by physical activity (output). Tilting the 
balance either way will alter one’s lean muscle mass; consuming more calories than one 
expends leads to a net gain in weight and consuming less leads to a net loss (Benardot 
and Thompson 1999). A study by Robert Demling and Leslie DeSanti in 2000 worked 
with overweight police officers and found that the subjects’ average daily protein intake 
was below the RDA. This low intake was likely a factor in the lean mass and strength 
loss experienced by the individuals. In order to increase muscle mass or reverse lean 
muscle loss, the nutritional goal would be to tip the nitrogen balance to the positive side 
by consuming a net positive intake of amino acids (Phillips et al. 2007).  
 One of the most important indicators of protein utilization in the body is the 
Nitrogen Balance, which is defined as the minimal amount of protein ingested that will 
balance all nitrogen lost (Tipton and Wolfe 2004). The Nitrogen Balance is what was 
used to calculate the RDA for protein and amino acids. This method, however, is tailored 
to find the minimum intake level necessary to limit deficiency and not for  optimal 
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athletic performance (Phillips et al. 2007).  Additional protein can be rationalized because 
all ATP expended for bodily movement must come from energy stores (Lemon 1987). 
Muscle and skeletal protein represents a small “pool” of reserve energy that can be 
utilized during physical activity in addition to glycogen and lipid stores. Because this 
pool cannot be expanded, there is no other way to store the amino acids (Phillips et al. 
2007). 
 There are restraints on the quantity of protein that can be consumed causing any 
excess protein to simply be stored as fat (Nemet and Eliakim 2007). Consuming surplus 
protein can also be a problem because of the nitrogen that is inherent in its structure.  
Nitrogen can be toxic and in excess will be converted into urea (Phillips et al. 2007). On 
the other hand, the body also reacts to high protein levels by increasing amino acid 
catabolism.   During exercise the body’s metabolism switches to a predominantly 
catabolic state. After exercise, during rest, the body shifts more towards anabolism 
(Tipton and Wolfe 1998).  
Amino acids in muscle building 
High quality proteins like eggs, dairy products and muscle proteins contain all of 
the twenty amino acids. This has been demonstrated with research showing that whole or 
skim milk consumption leads to a greater positive muscle protein balance and net amino 
acid uptake than soy based milks (Hartman et al. 2007). Amino acids are also the 
precursors to physiological compounds like creatine, epinephrine, and purine bases 
(Nemet and Eliakim 2007).   Amino acids can provide ATP for muscle contraction 
through direct oxidation or the conversion to glucose via gluconeogenic pathways. In 
addition, the availability of the necessary amino acids is a requirement for muscle protein 
 
 
11
synthesis (Levenhagen et al. 2002). Blood amino acid concentration has physiological 
signaling qualities like growth hormone, insulin, and insulin-like growth factor. This is 
dependent on the quality of the protein and the specific amino acids consumed (Nemet 
and Eliakim 2007). These amino acids function as regulatory molecules to stimulate 
muscle protein anabolism.  
Decreasing blood amino acid concentrations has been shown to result in 
decreased muscle protein synthesis, while increasing the concentration has restored the 
synthesis rate (Tipton and Wolfe 1998).  The physiological response changes depending 
on the protein type, differing even between two high quality proteins like whey and 
casein. Blood amino acid concentration is higher and adjusts more quickly after 
consuming whey protein, but anabolic response is greater with casein (Tipton and Wolfe 
2004). There is a notable difference in the resulting blood amino acid concentration after 
ingesting intact proteins when compared to hydrolyzed amino acids (van Loon et al. 
2000).    
Muscle catabolism is an integral part of growth. As the muscle contracts, muscle 
fiber damage occurs. The muscle is the site where the metabolism responsible for this 
movement occurs, and as a result, the increase in amino acid oxidation likely occurs in 
these sites as well. During rest, muscle anabolism occurs and the previously damaged 
muscle is rebuilt.  Muscle contraction leads to skeletal, structural, and membrane protein 
damage,  proportional to the extent of the physical activity. The eventual muscle 
anabolism leads to a greater need for available amino acids for the synthesis of new 
proteins (Levenhagen et al. 2002). Supplementation of energy in the form of 
carbohydrates and/or fat can provide the energy necessary for the exercise and post-
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exercise glycogen synthesis. Amino acids are, however, necessary for muscle protein re-
synthesis.  Muscle synthesis is influenced by the intramuscular availability of amino 
acids as well as blood flow. An increase in muscle synthesis increases the transport and 
delivery of amino acids to the muscles. The availability of these amino acids, either from 
the diet or resulting from muscle breakdown, may act as a signal for the eventual muscle 
synthesis (Tipton and Wolfe 2004).  
Essential Amino Acids  
Essential amino acids (EAA) are those that cannot be produced in sufficient 
amounts by the body, but are found in high quality protein sources (Nemet and Eliakim 
2007). There are nine EAAs: Lysine, threonine, valine, isoleucine, leucine, methionine, 
phenylalanine, tryptophan and histidine. Two of these (lysine and threonine) cannot be 
synthesized by the body and therefore must be consumed in the diet (Bos et al. 2000). 
EAAs are even more critical to the synthesis of muscle protein and represent a limiting 
factor in protein synthesis (Cribb 2006). Animal studies have shown that muscle 
synthesis is reduced when EAAs are withdrawn from the diet. The EAA content of a 
protein is seen as the indicator of the quality of the protein source (Table 2-1), EAAs, 
which include branched chain amino acids, stimulate lean muscle protein synthesis (Ha 
and Zemel 2003).   
 
 
 
 
 
 
13
 
Table 2-1: EAA’s in selected protein sources adopted g/kg air-dry wt (Rutherfurd and Moughan 1998) 
EAA 
BCAA 
 
Soy  
Protein 
Concentrate 
Soy  
Protein 
Isolate 
Whey 
Protein 
Concentrate 
Milk  
Protein 
Isolate 
Threonine  26.1 34.1 57.9 40.2 
Valine 33.9 44.4 49.1 61.1 
Methionine 10.0 12.6 21.8 29.1 
Isoleucine 31.5 43.1 52.2 49.5 
Leucine 54.2 71.0 88.2 94.4 
Phenylalanine 36.0 48.1 29.5 48.4 
Histidine 19.3 26.0 17.2 31.8 
Lysine  42.6 60.3 72.8 75.9 
Branch Chain Amino Acids 
There are three branched chain amino acids (BCAA): leucine, isoleucine, and 
valine.  They are a unique subset of the essential amino acids, accounting for 35% of the 
EAAs in muscles (Shimomura et al. 2004). BCAAs differ from other amino acids in that 
they are directly utilized in skeletal muscle as a source of energy (Nemet and Eliakim 
2007), and show significant oxidation during exercise. This unique ability may increase 
the availability of carbohydrates and reduce the impact of muscle breakdown during 
exercise (Walzem et al. 2002). Endurance exercise shows an increase in the amino acids’ 
oxidation, supporting the theory that BCAAs are of particular importance to endurance 
athletes (Phillips et al. 2007). BCAAs can also contribute to glucose production through 
the Cori cycle, due to their ability to form transaminase pyruvate in the muscle as an 
intermediate to alanine (Nemet and Eliakim 2007). BCAAs have also been shown to 
reduce exercise-induced muscle damage and increase the synthesis rate (Shimomura et al. 
2004). 
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Carbohydrates and Exercise Metabolism   
Exercise Recovery   
Some studies have shown that combining protein with carbohydrates in post-
exercise meals can improve recovery time (Zawadzki et al. 1992; Levenhagen et al. 
2002). Others report that the combination has no positive synergistic effect when 
compared to just carbohydrates alone (Jentjens et al. 2001). Much of the disagreement on 
the effects of combining protein with carbohydrates for improved recovery is due to the 
quantity of protein or carbohydrates provided and the style and extent of the exercise, as 
well as the method of measurement.  In a study that resulted in a zero net gain in muscle 
glycogen synthesis, blood insulin levels increased when protein and carbohydrates were 
administered (Jentjens et al. 2001).  Yet other studies found a net gain in muscle 
synthesis if protein was included in the supplements (Zawadzki et al. 1992; Kimball et al. 
2002).  This could indicate that insulin level may not be the rate-limiting factor in muscle 
glycogen synthesis but are affected by protein consumption (Jentjens et al. 2001). In this 
case muscle synthesis will be achieved as long as adequate carbohydrates are provided. 
Even without additional protein intake, nitrogen balance may be restored with only the 
consumption of carbohydrates (Phillips et al. 2007).  A protein-sparing effect occurs if 
sufficient carbohydrates are available, and protein oxidation will be ignored or reduced. 
In low carbohydrate diets, protein would be redirected for utilization as fuel instead of its 
anabolic use (Benardot and Thompson 1999).  As stated before, the major energy sources 
during exercise are lipids and carbohydrates (glycogen), while protein or amino acids 
account for only 3-6% of the ATP needed during exercise.  
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Endurance athletes generally “carbo load” consuming large quantities of 
carbohydrates before periods of extreme exercise. Consuming 7-10 grams of 
carbohydrates per kg of body weight is recommended for those participating in marathon 
events (Nisevish 2008).This “loading” leads to larger concentrations of available 
carbohydrates which are stored as glycogen, and if protein is also consumed, it improves 
the net protein balance and reduces protein utilization (Gibala 2007). It is becoming 
understood that amino acids play an important role in the intermediate steps of the TCA 
cycle (Gibala 2006). There is the potential for athletes to reduce stored fat and alter their 
body composition through consuming a low calorie diet, skewed towards higher protein 
consumption (Phillips et al. 2007).  Carbohydrates, if consumed in excess without 
adequate activity, are particularly prone to be stored as fat, and developing excess fat can 
lead to additional health problems (Demling and DeSanti 2000).  
Glycogen  
Glycogen is the body’s natural energy storage form for carbohydrates. It is the 
first and major energy source utilized during physical activity; however it is finite in 
quantity and must frequently be replenished.   Glycogen represents a relatively small 
store of energy, approximately 1500-2500kcal when saturated; this is due to the low 
energy density of carbohydrates (Hoyt et al. 1991).  After exercise, to restore glycogen 
levels to pre-exercise levels, an estimated supplement containing between 1-1.2 grams 
carbohydrate per kg of body weight is required (Phillips et al. 2007). Most evidence 
suggest that if adequate carbohydrates are consumed (>1.2 gram/kg body/ hour) the 
benefits of additional protein are negated. However, when protein is ingested with 
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carbohydrates, glycogen synthesis rate will increase if the quantity of available 
carbohydrates is low (Gibala 2007). 
Effect of Timing  
Consensus among athletes, trainers, and nutritionists is that consuming 
supplemental protein and carbohydrate at the end of exercise provides a better anabolic 
environment (Nemet and Eliakim 2007). One study found supplementing within one hour 
of exercising promoted greater gains in lean muscle mass compared to either soy or 
carbohydrate controls (Hartman et al. 2007).  Immediate post-exercise supplementation 
could benefit the endurance athlete in repair and synthesis of muscle protein and the 
reloading of glycogen (Gibala 2007). Protein consumption, whether consumed alone or in 
conjunction with carbohydrates, will be a major determinant in strength or muscle mass 
gains (Phillips et al. 2007).  
Protein Supplementation Case Studies  
Under conditions of weight loss, diets that contain more protein have been shown 
to lead to significantly less lean-muscle loss compared to diets high in carbohydrates 
(Layman et al. 2005). One study on protein utilization found that subjects who were 
deficient in initial glycogen stores before endurance exercise utilized more protein as a 
percentage of total energy expended (Lemon and Mullin 1980). In a study comparing 
high and low protein diets with two exercise treatments, those who consumed the high 
protein diet lost more body fat without disrupting HDL cholesterol levels (Layman et al. 
2005).  This seems to indicate that increasing protein in the diet could potentially 
improve the body composition of subjects during exercise.  Another study was conducted 
comparing a control containing only carbohydrates and fat to a treatment that also 
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incorporated protein. The results showed a twenty percent greater quantity of circulating 
amino acids (lysine, valine et al.) in the blood after exercise with the protein supplement 
(Levenhagen et al. 2002). The presence of the protein in the supplement seemed to 
reverse the catabolism that was seen with the control supplements. The hypotheses is that 
the limiting factor in muscle protein synthesis is not the overall energy consumed in the 
diet, but the amino acid concentration in the body as a result of the food consumed.  
Dairy as Functional Nutrition   
Milk Overview  
Milk provides all the nutrients necessary for the growth and development of the 
maturing mammal. Milks supply macronutrients as well as immunity compounds and 
micronutrients (Walzem et al. 2002).  The composition of milk varies depending on the 
species, stage of lactation, season, and a variety of other factors. Milk contains a 
combination of two major protein groups, wheys and caseins, each has specific functional 
and nutraceutical properties.  
Bovine milk contains on average 3.4% protein, which is primarily 80% casein and 
20% whey (Spreer 1998). Casein and whey proteins behave differently during processing 
and digestion. Casein will coagulate in the stomach forming clots that are harder for 
enzymes to proteolysie; however once in the small intestine they are absorbed quite 
readily. Whey proteins do not coagulate on contact with the stomach’s acid and are thus 
transferred quickly to the small intestine where they slowly become absorbed over a 
much greater length of time (Walzem et al. 2002).  
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 Milk has been shown to be an effective functional ingredient for promoting 
positive health and athletic performance. A study comparing a carbohydrate and soy 
supplement to a skim milk one in a controlled laboratory weightlifting experiment 
showed that skim milk increased the type I and type II muscle fiber areas greater than the 
soy and carbohydrate products.  Skim milk also increased the fat and bone free mass 
above that of the other treatments, and led to a greater reduction in fat mass (Hartman et 
al. 2007).  Milk’s protein profile is unique in containing all essential amino acids and 
high concentrations of BCAAs. Casein and whey have separate profiles, but even 
independently they score high compared to other protein sources (Table 2-2). 
Table 2-2 - BCAA composition of selected proteins, adopted form (van Loon et al. 2000). 
% by Wt  Casein Whey Pea Wheat 
L-Isoleucine 5.8 5.1 2.4 2.6 
L-Leucine  10.1 8.7 5.1 5.6 
L-Valine 7.4 4.5 2.7 3.0 
Casein  
Casein accounts for 80% of the protein in bovine milk. It is the fraction that is 
responsible for creating cheese because it is hydrolyzed by chymosin and its solubility is 
influenced by pH. Casein proteins have been shown to contain various peptides that have 
bioactive properties, and these peptides seem to require proteolysis of the main casein 
forms in order to be released (Shag 2000); (Walzem et al. 2002).  In the study of 
overweight police officers by Robert Demling and Leslie DeSanti in 2000, after twelve 
weeks, lean muscle gains were doubled and fat loss was fifty percent greater in the group 
which was fed a casein supplement compared to the whey group. Casein has four major 
subgroups (αs1, αs2, β, κ), each has multiple bioactive peptides with different abilities and 
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strengths. There appear to be several main substrates that are affected by these peptides 
(Shag 2000).  Opioids, known as casomorphins, have properties similar to that of opiates 
and have been seen to increase gastrointestinal transit time among other physiological 
effects. Immunomodulating peptides have been shown to affect T-cells and macrophage 
activity. In addition, antihypertensive, anticariogenic, and antithrombotic properties have 
been observed. Hydrolysate components of casein have been shown to decrease amino 
acid oxidation and net protein breakdown, leading to improved nitrogen retention 
compared to other supplements available commercially (Demling and DeSanti 2000). 
Unlike whole or native protein, hydrolysates have also been shown not to stimulate the 
release of the hormone cortisol, which has lipogenic and catabolic properties.   
Whey  
 Whey proteins represent the minor portion of total milk protein, 
accounting for approximately 20% of the total. Whey protein exists at the same 
concentration in human milk as in cow milk. However,  human milk contains no β- 
lactoglobulin and cow milk has a much lower level of lactoferrin than human milk (Bos 
et al. 2000). Whey protein has also been identified as a possible source for bioactive 
peptides. After ingestion, whey protein leads to a very rapid oxidation and whole body 
protein synthesis. Casein, on the other hand,  leads to whole body proteolysis suppression 
(Hartman et al. 2007). Whey is composed of several protein fractions including β- 
lactoglobulin, α-lactalbumin, proteose-peptones, and blood proteins (Walzem et al. 
2002). The majority of these peptides seem to have influence on the immune and 
digestive systems such as chelating, antimicrobial and antioxidant activity. In addition 
immunoglobulins have potential anticancer and antitumor effects (Shag 2000). Whey is 
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also said to have hypocholesterolemic properties which might actually “balance” out the 
possible negative health effects of the saturated fat naturally occurring in milk (Walzem 
et al. 2002). Whey protein contains a high proportion of sulfur-containing amino acids 
(cycteine, methionine), which are said to contribute to the higher protein efficiency ratio 
(PER) of whey. Whey may also lead to the sparing of tissue proteins ordinarily used in 
response to immune challenges (Walzem et al. 2002). Whey proteins contain high 
amounts of EAA and BCAA which are generally lacking in plant and other protein 
sources (Table 2-1). As a byproduct of cheese production the whey stream is seen as a 
rich source of BCAA, equaling at least 26% of the total amino acids present (Bos et al. 
2000). The amino acid composition of whey is said to be relatively similar to that of 
skeletal muscle, making whey a good source of amino acids during muscle re-synthesis. 
Minor Components 
Components beyond the macronutrients of milk, such as minerals and 
carbohydrates, have also gained recent attention.  Lactose has the ability to form 
oligosaccharides which have both specific and broad prebiotic properties. These 
oligosaccharides can be labeled Generally Recognized As Safe (GRAS) for use in 
products desiring enhanced probiotic effects. Lactose may also influence the absorption 
of calcium, which in turn is said to have a role in regulating blood pressure. Milk 
enzymes do not appear in finished products as they are deactivated during pasteurization. 
However there is emerging research on particular enzymes like lactoperoxidase which is 
used as a preservative in some products (Walzem et al. 2002). Lactoferrin, another milk 
enzyme of interest, has iron-chelating, cation transport, and anti-infectious properties. 
Lactoferricin, a form of lactoferrin, also has bactericidal activities (Bos et al. 2000). 
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Buttermilk, the by-product and liquid phase of butter manufacturing, has been seen as a 
source of potential bioactive components.  Sphingomyelin and phospholipid have been 
demonstrated to have anticancer properties and are concentrated in the buttermilk fraction 
(Walzem et al. 2002).   
Nutritional Bar Development 
Target Formulation Constraints  
The goal of developing this RTE bar is to supply high energy and a designated 
percentage of the RDA of calories, as well as a combination of all of the macronutrients. 
Incorporating dairy protein into a RTE bar is a preferred method of directly reversing the 
negative effects of lean muscle loss through the diet. Development of the RTE bar 
focused on delivering the maximum nutritional functionality to the end-user.  
The form and source of protein in a food product is of great importance, in that it 
must appeal to the target market, meet nutritional objectives and function appropriately in 
the formula (Hazen 2008). The quality of protein consumed is very important for 
maximizing the anabolism of muscle protein. The high-quality proteins in milk, dairy 
products, eggs, and muscle meats are ideal (Phillips et al. 2007). Another measure of 
protein quality, without measuring the concentration of individual amino acids is the 
Protein Digestibility Corrected Amino Acid Score (PDCAAS) (Hazen 2008) (Table 2-3). 
From this perspective, dairy protein, in particular whey protein, appears to be best suited 
for a protein bar product. In addition to their nutritional properties, whey proteins have 
critical functional properties that make them practical in bar formulations. They retain 
moisture, have a mild flavor, contribute to extended shelf life, lead to reduced 
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cooking/baking losses, and can be used to replace carbohydrates (Runestad 2004).  The 
quantity of high-quality protein is also important; 20-25g appears to be the upper limit to 
stimulate muscle protein synthesis, and would be an ideal maximum in a single-serving 
product. Above this level amino acid oxidation and urea formation become more 
prevalent (Phillips et al. 2007), diminishing the effectiveness of adding protein. 
Currently, the military serves Meal Ready to Eat (MRE) to soldiers in the field. These are 
lightweight and contain several separate packages that represent a full meal when eaten 
together. One concern with the use of MRE’s is that the macronutrients are not evenly 
distributed in the different components. This allows the soldiers to “field strip” or  
selectively eat portions of the ration and therefore not gain all the intended nutrients from 
the meal (Anonymous 2006). The goal of an optimal nutrition bar is to be a high energy 
snack or small meal that provides a designated percentage of the calories and all 
macronutrients needed by an individual in a day.  
Table 2-3: Protein Comparisons by Source: PDCAAS (Hazen 2008), Biological values (Runestad 2004) 
Source PDCAAS Value Biological Value 
Whey 1.0 104 
Egg 1.0 100 
Soy 1.0 74 
Pea 0.86 - 
Hemp 0.46 - 
Wheat - 54 
 
The Committee on Optimization of Nutrient Composition of Military Rations for 
Short-Term, High-Stress Situations 2006 lists the following recommendations for the 
development of a ration: 
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 Protein and carbohydrates are the priority 
 Fat is important for palatability and absorption of fat soluble vitamins 
 Weight and volume restriction of: 0.12 cubic feet, 1.36kg 
 Shelf life of 2-3 years 
 Individual portions that can be easily distributed in backpacks 
 Palatability is a primary concern 
 Variety of familiar flavors, colors and textures 
 Potential for either sweet or savory formulations. 
Nutrition bars are among the easiest products to fortify. They have an easy dry 
mixing stage, low thermal processing (if any), and they generally utilize opaque laminate 
packaging (Hazen 2009).  The main challenge with the formulation of nutrition bars is 
the drying and hardening that occurs during storage and throughout the shelf life 
(Runestad 2004). This problem is compounded by the long shelf life and humidity 
standards set by the military, as well as the moisture and water activity in the bar. Water 
activity (aw) is an important property of foods that will help dictate food safety, shelf life 
and textural parameters. The water in the product migrates over time to the protein and 
the dry ingredients, which will alter the intended texture (Hazen 2010).  Higher aw will 
result in a softer bar, however there is a limit to this as shelf-stable bars need to be at an 
aw level of less than 0.65 for food safety reasons (Hazen 2010).  A consideration that 
should be taken into account with an RTE bar is that protein metabolism requires more 
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water than either lipids or carbohydrates (Lemon 1987). This could be problematic for a 
product that contains high protein levels but low moisture content. This makes the option 
of hydrating the RTE bar a more effective means of delivering the desired product 
nutrients.  
Ingredients  
Dietary Fiber 
Dietary fiber is an interesting ingredient from a formulation perspective. It is 
desired because it has minimal nutritive properties. Dietary fiber under the current 
definition pertains to fibers that are indigestible but can be utilized as a prebiotic fiber in 
the small intestine. Fiber can also be an important component in a bar formulation, 
providing necessary nutrition and digestive functionality. Fibersol-2 (see appendix page 
131) is a commercial ingredient which is labeled as a resistant starch, it provides dietary 
fiber and helps with texture throughout the product shelf life (Runestad 2004). 
Delactosed Permeate  
Delactosed permeate (see appendix page 130) is a novel dairy ingredient 
developed using the waste stream of WPC concentration. It has a high mineral 
concentration ~ 30% ash, with high calcium content at 3.7%. Delactosed permeate 
contains oligosaccardies and many micronutrient ingredients. Therefore it could be used 
to boost calcium and vitamin content in a particular formulation targeted to women or the 
elderly. There is also recent research that points to success in using Delactosed permeate 
as a salt replacement in bakery products. This would help the product become more 
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attractive to individuals struggling with hypertension or individuals simply looking for 
low sodium foods. 
Flavor  
From the onset of this project there has been the concept of developing a savory 
form of the RTE bar. The majority of bars that are on the market today are sweet (Hazen 
2009). While there is interest in the concept of a savory bar, there is little indication that 
the market would accept it. This is likely a result of the current standard formulations 
used by most producers and expected by consumers. Currently available bars contain 
significant amounts of HFCS to act as a binder, or contain carbohydrates as a major 
ingredient, and often use bitter tasting protein blends. These qualities lend themselves 
more to a sweet formulation than a savory one. However, considering the specification of 
the RTE bar as high protein with a mild dairy flavor, a savory option might be 
achievable. 
Bar Processing  
Freeze Drying  
Freeze drying preserves food by removing free and bound water.  It has many 
commercial and industrial applications and is used in the processing of high value and 
biologically active products (Oetjen and Hasely 2004). Freeze drying may be the 
processing method of choice for the RTE bar because of its low processing temperature. 
Freeze dried products are easy to rehydrate and still retain biological activity. Freeze 
drying relies on the properties of water sublimation, that is the bypassing of the liquid 
phase in the transition from a solid state to a gaseous state, to remove the water from the 
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product with minimal heat input. Sublimation occurs when the partial pressure of the 
environment is below that of the product so the frozen water must evaporate to create 
equilibrium. However, the water vapor is constantly being removed by the condensation 
coil which maintains sublimation. A basic freeze dryer contains four parts (Jennings 
1999): 
 A chamber that can be both temperature and pressure controlled 
 Vacuum pump which lowers the pressure and removes some gases 
 Heating plates that provide heat to increase the sublimation rate 
 And a refrigerated coil that removes the sublimated vapor from the chamber’s 
environment by creating a temperature gradient.  
To freeze dry, first the product must be completely frozen to a very low 
temperature. This is generally done in the blast freezer at a setting of -14oF. The 
sublimation of the frozen water occurs after the samples are placed in the chamber and 
the heating plates and vacuum are set to the desired levels. Without being placed in the 
pressure-controlled atmosphere, the ice would simply melt.  The heating plates provide 
enough minimal radiant heat to supply the latent heat of sublimation (1075 BTU/LB or 
2495.08 KJ/KG). Secondary drying occurs after all free water has been removed; the 
product will appear dry but still contains bound water.  This water can also be removed 
with resulting theoretical moisture content between 1-5%.  
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3.    BAR FORMULATION AND MANUFACTURING 
Introduction and Experimental Logic 
Stable energy balance and physical health are critical factors for certain high risk 
groups like soldiers and endurance athletes. Such individuals depend on their strength 
and stamina to do their jobs and often have restricted carrying capacity, limited time to 
eat, and unbalanced meals. Stress has a profound effect on the human body which is 
compounded by a poor diet. If appropriate safeguards are not taken there is the potential 
for lean muscle loss and long-lasting physical and psychological deterioration.  A 
reduced calorie diet, especially one that lacks high quality protein, is one of the main 
causes of this physiological stress. There is the possibility of mitigating this risk with a 
well-balanced high protein (RTE) nutrient bar. The specifications (Table 3-1) for such a 
product are designed to provide the required high energy nutrients within the time and 
space constraints. 
Table 3-1: RTE bar physical and nutrition specifications 
Ready To Eat (RTE) Bar Specifications 
Weight: 100g  Intermediate moisture range 
Total Calories: 400kcal per serving   Nutrient and product stability  
Protein Content: 25grams protein  Contains a majority of dairy ingredients  
 
To meet the above specifications, the ingredients must be carefully selected, 
particularly the protein source. Based on the current scientific understanding of protein 
metabolism, providing a high quality protein (Table 2-3) would be the most effective 
method for achieving this. This would ensure that any and all amino acids would be 
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available in adequate amounts to support the anabolism of muscle. Dairy protein was 
considered the best option, for the RTE development and more specifically, whey protein 
due to its extensive use in similar commercial products, and the relatively high 
concentration of BCAA (Table 2-2) involved in muscle contraction. However, whey 
protein is just a fraction of milk, lacking casein and dairy lipids. Considering this we 
undertook to develop a more suitable protein source from milk to provide the needed 
protein profile, which could offer superior nutritional benefits to whey protein alone.  
In addition to the protein type, the specific processing method for such a bar is 
important. The military has stringent guidelines for their current rations which include a 
2-3 year shelf life, nutrient stability, and small compact size (Anonymous 1994). In order 
to meet these specifications, freeze drying was chosen as the processing method for the 
RTE bar. More common drying processes, such as baking, vacuum, and air drying, were 
also investigated. Several micronutrients and probiotics were then considered as possible 
additives to the basic RTE formulation. Probiotics are of growing interest to the food and 
dairy industries (Stanton 2001), consumers are becoming aware of probiotics and 
demanding them in foods they commonly eat. Processors are also recognizing the 
potential of probiotics to increase their market share and provide a novel method of 
delivering targeted nutraceutical properties (Ouwehand 1998). Probiotics would be an 
ideal addition to a nutritional bar formulation; the challenge is ensuring the survival of 
the active probiotic organisms which are limited by the relative instability of organisms 
during processing and storage. 
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Materials and Methods  
List of Ingredients 
 Hilmar 8200 whey protein concentrate (WPC): protein source and filler. Typical: 
82.5%, Specification: 80.0% min Protein.  
 Milk Protein Precipitate (MPP): Ricotta-like cheese manufactured in-house, 
protein source, binder and filler. Protein 22-27%, Moisture 35-40%. 
 Buttermilk Powder (BMP) Dairy America: protein and micronutrient source. 
Protein 32 - 34.5%, Fat 5.5 - 6.0%, Lactose 49.0 – 50.5%.  
 Non Fat Dry Milk (SMP): filler and control ingredient to BMP. Protein 36%, 50% 
lactose.  
 Bread flour (high gluten): filler and carbohydrate source. 73% carbohydrate, 12% 
protein. 
 Sucrose: Filler and sweetener. 
 Non-Iodized Salt: Flavor enhancer, water activity control.  
 Cornstarch: Binder, moisture retention. 
 Sweet Cream Butter: Lipid source, calorically dense. 80% Fat. 
 Experimental test ingredients: puffed millet, high fructose corn syrup (HFCS), 
corn syrup, de-lactose whey permeate, Fibersol-2, shortening, water, flavors.     
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moisture and water activity in the product. Reducing the moisture increases the energy 
density of the product as moisture content adds weight but not calories. In addition, 
drying the bar reduces the water activity (aw) of the bar. This limits the growth of 
spoilage organisms by reducing the water needed for their growth. Processing also affects 
the palatability of the RTE bar, which is highly dependent on the texture and mouthful. 
Several different processing methods were investigated (Table 3-2) and adapted to meet 
current and specific project goals. 
Table 3-2: Summary of RTE processing methods  
Method Time Temperature Pressure  Moisture 
Freeze  Drying  2-8 hours  Product:30oC 
Plate:100oC  
0.35mmbar 1.5% 
Vacuum Oven 4-16 hours 25-55oC  25”Hg >15% 
Forced Air Drying  2-10 hours 150oF  Atmospheric  ~28% 
Convection Baking  1.16 hours 250oF Atmospheric ~25% 
Freeze Drying  
Several heating parameters were investigated to achieve the best product using the 
freeze drier. While some batch to batch variability still existed, the majority of this was 
removed when the product was rolled to an even thickness and perforated using a roller 
docker. The holes created by the roller docker acted as channels for the water vapor to 
leave the product. Without holes the product would balloon up in some sections, creating 
hollow cavities which would fracture the product.  The maximum temperature setting can 
be adjusted for both the plate temperature and the product temperature. Plate temperature 
refers to the heating element supplying the radiant heat. Product temperature refers to the 
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Baking took place immediately after the dough was rolled out to the specified dimensions 
(11.5” x 14.5” x 0.5”) (Figure 3-8).  
Baking Procedure   
1. Preheat convection oven to 250oF. 
2. Bake sheet on middle rack for 25 minutes. 
3. Rotate sheet 180o, bake an additional 25 minutes. 
4. Remove tray from oven and allow to cool for 15 minutes. 
5. Cut sheet into the specified individual unit size (Figure 3-9). 
6. Flip individual bars 180o over the top, return to baking tray. 
7. Bake for an additional 20 minutes. 
8. Remove from oven, allow to completely cool before packaging. 
Vacuum Drying 
This method was explored as a less expensive alternative to freeze drying, 
requiring only low thermal heating and no initial freezing. A vacuum oven generally used 
for moisture analysis was used to investigate this method (Figure 3-13). The required 
drying time depended on the amount of sample in the chamber and whether the chamber 
was heated. At ambient temperatures almost fourteen hours were necessary; only four 
hours were needed at 35oC to dry the product to a final moisture content below 20%.  
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Forced Air Drying  
Dough was dried using a Harvest Saver air dryer designed to dry fresh fruit and 
vegetables. Using this commercial dryer, air velocity and temperature can be controlled. 
After several trials this method was deemed to be ineffective. It led to incomplete and 
inconsistent drying with very long processing times.    
Protein Ingredients  
Whey Protein Concentrate (WPC)  
WPC 80 is the standard dairy-sourced protein used in the industry for bars and 
processed foods, from breakfast cereals to salad dressings. It has such far-reaching uses 
due to its superior functionality. It can provide texture, body, and nutrition (high 
concentration of EAA and BCAA). WPC was the first and primary protein used in the 
RTE formulation and continued to be used to boost protein content in later formulation 
trials (See appendix page 111). WPC represented up to 50% of the dry weight in some 
formulations, providing the bulk structure where carbohydrates are generally used in 
commercial bars.  
Milk Protein Precipitate (MPP)  
The shredded MPP curd is treated as a fresh ingredient which must be refrigerated 
and has a relatively short shelf life.  The MPP was easily incorporated into the existing 
RTE bar formula because it mixed readily and did not clump.  The MPP was added 
during the “wet” ingredient mixing stage (Figure 3-4). Initially, the mixture looked dry 
and non-cohesive. After mixing the moisture in the MPP begins to hydrate the starch and 
other ingredients causing the formation of uniform dough. MPP was utilized in several 
products as a unique protein source (See appendix page 129).   
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Skim and Butter Milk Powders 
SMP and BMP are both relatively inexpensive products compared to WPC since 
they have a much lower protein concentration (30-38% dry basis) (see appendix page 
109-110).  These ingredients add protein and nutritional value to a formulation; however, 
they are not necessarily utilized as such in the industry. These ingredients generally are 
treated as fillers increasing the total solids of products. In addition, BMP and SMP have 
higher lactose contents which could make them less desirable in a nutrition bar 
formulation.  Commercial BMP was used initially as an ingredient that could be replaced 
with a specially manufactured BMP powder with high phospholipid and sphingomyelin 
contents.  
Micronutrients and Flavor Development 
Several experimental formulations were tried in order to improve the overall 
nutritional benefit of the bar. These were executed as proof-of-concept trials to observe if 
ingredient additions would negatively impact the flavor of the product. The nutritional 
profile of bars can be easily modified to meet specific market or consumer demands, such 
as bars with high calcium, high fiber, or low carbohydrate (Hazen 2009).  
Delactosed Permeate  
Two levels of Delactosed permeate addition were tried, in two different 
formulations of 2% and 4% dry basis, to the base formulation. The finished product was 
compared from a sensory perspective and the ash content was also analyzed (see 
appendix page 106).  
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Dietary fiber 
Dietary fiber in the form of Fibersol-2® was added to the dough mix at various 
levels in substitution for flour. (See appendix page 107).  
Flavor  
Considering the importance of the sensory properties of the RTE bar, both sweet 
and savory flavors were tried. Liquid and powder flavors were added to formulations 
during dry mixing at the manufacture recommended levels. Cheese, chicken, BB-Q, pasta 
and mushroom, fruit, and vanilla flavors were tried (Table 7-1).  
Probiotics   
Probiotics need to be viable in order to provide their benefit, thus the initial 
survival of the probiotics during the processing is of special importance.  Two processing 
methods (vacuum drying and freeze drying) and three potential probiotic lactic acid 
bacteria (Table 3-3) were investigated to see how they responded to the process and 
formulation treatments. In addition BMP and SMP were added as treatments to see if any 
synergistic effects exist between BMP and the probiotics survival. 
Table 3-3: Three probiotic stains used in survival study 
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overnight. The following day the mixture was heated to 105oF, Danisco YO-MIX 533 40 
375 DCU yogurt culture was added at 0.0002% w/w, and it was left to ferment for 
approximately three hours.   
Results   
Formulation  
Table 3-4 shows the recommended formulation for further development. The 
initial formulation should be considered a “dry mix” formula; this could be produced 
using conventional current processing methods and ingredients. This formulation uses 
WPC as a sole protein source. The final formulation uses the MPP ingredient as well as 
WPC as the protein sources. 
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Table 3-4: Initial formulation was utilized in several processing trials and the probiotic survival study The final 
formulation was used in the physiological validation of RTE study,  
Ingredient Initial Formula  Final Formula  
MPP -  62.1 
WPC 24 18.8 
Sugar -  10.3  
HFCS  21 -  
BMP 14 - 
Butter  15 - 
Water  12 -  
Flour 8 3.7 
Corn Starch -  1.88 
Puffed Millet*  6 -  
Salt  - 1.5  
Flavor: Gold Coast #342991 - 1.4 
Sucralose - 0.1 
Total 100 100 
*: Ingredient substitute for whey protein crisps, Table 3-5 
 
 
Table 3-5 Displays protein content and flavor observations of RTE bars 
formulated using whey protein crisps.  Flavor observations were made by three subjects 
in an informal product evaluation.  
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Table 3-5: Qualitative and quantitative results of substituting millet with whey protein crisps.  
Tested Ingredient* 
Table 3-4 “Initial 
Formula”  
Final Protein 
Content   
Final Product Observations  
TF1: Millet  22.62 Millet holds dough together, good clean 
flavor, no change to texture  
TF1: 50% protein crisps  37.60 Crisps had weak structure, fragmented in 
mixer, absorbed water and became mushy 
TF1: 70% protein crisps 32.74 Bitter astringent flavor, required greater 
amount, very hard to chew  
 
Table 3-6 Displays the effects of Delactosed permeate added to formulations. The 
data was used to predict the effect and possible use level of Delactosed permeate. There 
were no perceived sensory differences between the control and added permeate products, 
although TF2.2 appeared to have a sweeter flavor.  
Table 3-6: Protein and Ash content of two experimental formulas and trials to increase ash content using a 
“Delactosed” permeate (Delact) product. 
Sample Number  Protein  Ash 
TF2.1: Control 34.8 1.54 
TF2.1: 2% Delact 34.1 2.2 
TF2.2: Control  35.7 2.0 
TF2.2:  4% Delact 34.6 3.3 
 
Table 3-7 Displays water activity (aw) of several sample RTE bars. Number 1 is 
an early formulation before the addition of salt. Number 2 is the final formulation used in 
the Physiological Validation Study and contains salt. Number 3 and 4 are from the same 
batch but were located in different regions during baking.   
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Table 3-7: Water activity (mean of two samples), of select RTE bars after baking, comparing formulation, 
processing and position during baking.  
Sample  aw  Moisture Content  
      Bake formulation (no salt) 0.905 22.7 
Bake formulation (with salt) 0.890 20.7 
Baked Edge  0.876 21.8 
Baked Middle  0.885 22.8 
 
Processing  
Table 3-8 Displays the average moisture content of the RTE bar after processing. 
The target moisture content of the bar is >25%. Each processing method is capable of 
reducing the moisture content of the product, baking however results in a final moisture 
content which is closer to this specification.   
Table 3-8: Moisture content and aw of RTE bars before processing (raw) and after processing. Each 
measurement is an average of several (n≥2). Moisture content is calculated on a wet basis, using a moisture oven.  
Water activity (aw) is measured using an aqua lab water activity meter.  
Processing Comparison  
Processes  Moisture Content  aw 
Raw 39.0 0.99 
Baked  24.0 0.89 
Baked + Vac 17.0 0.85 
Vacuumed Dried  16.0 0.24 
Freeze Dried  8.8 0.1 
 
Table 3-9 displays the variability that exists in three batches of RTE bars made 
consecutively using formulation TF2.3. The results indicate the relative consistency in 
the formulation and processing of the bar.      
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Table 3-9: The moisture and protein contents on wet basis of in-between 3 batches produced in sequence. 
Moisture calculated using vacuum oven method; protein calculated using Rapid-N-Cube.                      
Batch   Protein Moisture 
A 36.1 19.25 
B 35.2 20.5 
C 36.5 18.84 
 
Probiotic  
Table 3-10 shows the statistical results from a probiotic survival study; the source 
heading lists the different factors that were tested, Prob> F lists the probability that the 
predicted result would occur randomly without being influenced by the before-mentioned 
factors. If a factor has a p value below 0.05 then it can be stated to have a statistically 
significant effect.  
Table 3-10: Statistical results from a probiotic survival study. Process: freeze dried, vacuum dried. Formulation: 
SMP, BMP. Probiotic: MR220, NCFM, 23272.  
Source  F Ratio  p Value  
Formulation 0.0042 0.9496 
Probiotic 3.0292 0.0853 
Process 0.0447 0.8335 
Probiotic*Formulation 2.8586 0.0957 
Process*Formulation 0.0239 0.8778 
Process*Probiotic 1.6512 0.2031 
Probiotic*Formulation*Process 0.4231 0.6575 
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Table 3-11 shows how the Least Sq mean of a particular treatment combination is 
the mean of viability for that treatment combination. Superscript values show the 
treatment combination groups (NCFM | BMP with 23272 | SMP and NCFM | SMP); if 
any share a superscript then they are not significantly different from each other. If they 
have different superscripts then they are significantly different.   
Table 3-11: Tukeys multiple comparisons= T-Test α=0.05, Least Sq Mean= Mean of % viability  
Treatment Combo  Least Sq Mean 
NCFM-BMP
a
  24.32
23272-SMP
a,b
  14.78
NCFM-SMP
a,b
  11.00
MR220-SMP
b
  8.14
23272-BMP
b
  6.39
MR220-BMP
b
  3.96
 
Figure 3-16 shows the concentration of probiotics in the raw dough (initial) and 
after processing (vacuum and freeze dried). Measurements are in CFU/gram and were 
found using the standard plate count method.     
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Figure 3-15: Mean CFU/gram (n=18) of selected probiotic strains before (initial) and after processing (freeze 
and vacuum dried.) 
  
Flavor  
Flavoring of the RTE was modifed continually throughout the development 
process. No formal sensory analysis was conducted but comments and observations were 
collected form advisors and peers. Flavors were ordered from several flavor houses 
(Firmenich, Gold Coast, IFF),and both liquid and powdered flavors were used.  Savory 
(Chicken, Cheese) and sweet flavors (Cranberry, Vanilla) were tried. The Physiological 
Validation Study utilized a Cranberry flavor to create a sweet bar; no final flavor profile 
was selected. See page 113 in the appendix for a full profile of flavor codes and 
observations.   
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Discussion     
The development of the RTE bar focused on two separate but related parameters. 
First the RTE formulation which would influence both the nutritional profile of the bar 
and dough consistency. Second the processing of the bar, which affected the shelf 
stability and protein content of the bar.  
Formulation   
The product development process resulted in two final formulas (Table 3-4), and 
both met the stated RTE parameters (Table 3-1). The two formulations provide the 
desired nutritional. The ingredients, mixing order, and resulting dough can be easily 
scaled-up  for mechanized industrial production.  The initial formulation utilizes dry 
shelf-stable ingredients that are combined with HFCS and water. This formulation could 
be produced using existing ingredients and processing equipment.  The final formulation 
uses a wet MPP protein which was developed in house for this project and is outlined in 
Chapter 4. This formulation delivers the optimum protein because it combines a complete 
precipitation of milk protein with supplemental WPC. The bar containing the MPP 
ingredient was used in the Physiological Validation study (Chapter 5).  
The dough in the initial formulation had the consistency of a viscous paste which 
did not hold shape and was tacky (Table 3-4). In order to improve dough consistency 
puffed millet was used to “bind” the other ingredients and give the resulting dough 
structure. The use of puffed millet, which has a high surface area and low density, 
improves the dough consistency and made it easier to handle. As a result the dough with 
puffed millet that can be rolled, had structure and is not sticky.  However the millet does 
not contribute to the desired nutritional profile of the RTE bar. A study was designed to 
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compare the feasibility of substituting the puffed millet for a “whey protein crisps” 
(Table 3-5). The use of whey crisps is common in the bar manufacturing industry, they 
available in various sizes and protein contents. Whey protein crisps would contribute to 
the “energy dense” dairy ingredient profile of the RTE. Three separate RTE batches were 
produced to compare the protein contents and dough functionality of the formulas with 
whey protein crisps versus the puffed millets. The resulting protein contents were 
approximately 22% in control millet RTE, 37% using 50% protein crisps and 39% using 
70% protein crisps. This trend is be expected because the protein content of the whey 
protein crisps contribute to a higher protein content in the finished RTE bar.  The whey 
crisps were much denser and larger quantities were needed to deliver the same dough-
binding effect. Additionally both whey protein crisp formulas, had noticeable stale or 
bland off-flavors that were detected in the finished RTE bar. The final protein levels were 
considerably higher than the target (25% for a 100g bar) and the whey protein crisps 
delivered lower functionality than the millet control. The whey protein crisps would 
shatter in the mixer, absorb water, lose their crispiness, and increased dough density. Due 
to the low functional performance the whey protein crisps were not used in subsequent 
formulation as the puffed millet delivered the desired dough profile. The 50% whey 
protein crisps might have future application in RTE bar formulation if higher total protein 
or EAA content is desired. The whey protein crisp damage seen in the preliminary trials 
could likely be reduced by using different mixing methods.   
Table 3-6 displays the proof of concept for use of Delactosed permeate in the 
RTE bar formulation. Delactosed permeate is a dairy derived calcium supplement that 
was added at varying levels to test its effect on mineral content and flavor profile. When 
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compared to the control sample, the mineral content (expressed as percent ash) increased 
in both formulations when Delactosed permeate was added. This indicates increased 
calcium content in the finished bar which would be favorable in an RTE bar product. 
Increased calcium intake is beneficial for athletes due to its relationship to muscle 
contraction and hormone function (Anonymous 1997).  Delactosed permeate contains 
mostly calcium which would interact through ionic binding with water to lower the aw of 
the RTE.  No noticeable off textures were noticed when consuming the RTE containing 
Delactosed permeate, and the dough consistency was not noticeable effected.  However, 
theses bars were baked and considered sandy and coarse prior to adding Delactosed 
permeate. The TF2.2 control contained a greater ash content compared to TF2.1; this is 
due to the higher WPC and BMP content in the TF2.2 formulation both of which have 
high mineral contents.  
The RTE bar water activity was an important parameter. When baking was used 
as the processing method the water activity of the RTE bar was substantially higher than 
the target (0.65). To try and control this salt was added at varying levels between 1.5-2% 
Table 3-7. Adding salt to the formulation lowered the final product aw from 0.950-0.895. 
This is due to salt’s ability to lower the water activity by ionic binding of the otherwise 
available water.  However, adding salt as the sole means to control aw will not be a 
practical solution as very high concentrations of salt would be necessary to achieve shelf 
stability. Samples for water activity and moisture content taken from the center and edge 
of the baking tray indicated that batches were homogeneous in terms of moisture 
distribution.  
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Flavor 
Flavor, texture, and the nutritional profile of the RTE bar, along with the dairy-
heavy ingredients make this bar an ideal product for a savory formulation. The majority 
of bars currently on the market are sweet. This is due consumer expectations and the 
common use of sweet syrups and fruit pastes as binding agents.  Although chicken and 
meat flavors may not be appealing, nacho or “Cheez-Its” flavors have a potential to work 
well.  
Delactosed permeate increased the ash content of the formulation which indicates 
an increase in calcium (Table 3-6). Additionally, Delactosed permeate is said to have 
salt-reducing and flavor-enhancing properties. These functionalities were not observed in 
this particular study, however TF2.2 (Table 3-5) was perceived as sweeter in both control 
and Delactosed samples. This was caused by the higher lactose content of the WPC and 
BMP formulation compared to the MPP only.  
The volunteers in the Physiological Validation Study were asked to evaluate the 
bar they consumed. This bar was processed through baking, and the formulation is 
present in (Table 3-4). Subjects stated that the bar was dry and found it difficult to 
consume a complete serving. Many also described the RTE bar as unsatisfying after the 
strenuous hikes, preferring the carbohydrate bar. The majority of the subjects liked the 
control bar, the reasons being the flavor, level of sweetness, and texture. Several subjects 
indicated that the RTE bar had a “corn bread” like texture. 
Shelf Life Expectations  
No formal shelf life study was conducted; however, informal observations of bars 
over time followed the expected trends. Freeze dried bars with moisture <10% and water 
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A formulation designed for baking was developed adding a thermal processing 
step which would limit food safety risks. The target was a finished product with low 
moisture content (~20%) and a water activity (< 0.65).  This would produce results equal 
to the freeze drying process.  However the low water activity level was never achieved. 
Table 3-8 shows the moisture drop that is achieved from the raw unprocessed dough to 
the finished baked product. The moisture content was close to the desired 24% compared 
to <20%. Although the low moisture objective could be reached with a slight alteration to 
the baking time, the water activity remained too high even after the addition of salt. This 
resulted in a bar that is not shelf stable and requires refrigeration for extended storage. 
Although baking was a viable processing method to achieve the nutritional parameters, it 
resulted in a RTE bar with a short shelf life.   
The baking process was optimized (Chapter 3: Baking) by controlling for within-
batch and between-batch repeatability. Three batches were made consecutively to study 
flavor profiles (Table 7-1), comparing different berry flavors at the same use level. The 
batches used the same formulation and processing parameters and the final moisture 
content levels of all three were collected (Table 3-9). These results were used to interpret 
the variability that can occur between different batches of baked RTE bars. The results 
showed that the random variability was not great (0.5-2.5%), and that the desired low 
moisture content could be met.  
Vacuum drying was investigated as an alternative processing method for the RTE. 
Vacuum drying does not require any prior freezing of the product as in freeze drying. It 
can remove the majority of the available water resulting in a moisture content of 
approximately 16% and aw below 0.24. This stability is achieved because the processes 
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take place at a lower pressure environment where the boiling point of water is reduced, 
which allows the free and available water to evaporate at a lower temperature. 
Additionally the vacuum creates a draw which removes the moisture from the chamber. 
The vacuum oven used was not large enough to make the quantity of bars necessary, thus 
halting additional vacuum processing research. 
 
Probiotics  
To test the practicality of inoculating viable probiotics into the RTE bar, their 
survival through the initial processing had to be verified. This study was a multi factorial 
(2x3x2) experiment comparing the effects of:  Formulation (BMP-SMP), Probiotic strain 
(NCFM, MR220, 23272), and Process (Freeze Dried, Vacuumed Dried). Initial statistical 
analysis of the data collected indicated there were no significant results in the analysis 
(Table 3-10). This can be interpreted as no combination of treatments resulted in any 
different level of survival than another. The Probiotic | Formulation interaction which 
was compared in the initial analysis showed a p value approaching significance, 0.09 at 
an alpha of 0.05. 
 If a multiple comparisons model is made of this interaction NCFM | BMP is seen 
as separate from three of the five combinations which are all in one group (Table 3-11). 
While this is not statistically significant it does indicate a trend which could be further 
investigated. NCFM is a widely studied strain because of its binding potential to the milk 
fat globule membrane (MFGM). In this study it resulted in a significantly higher viability 
when BMP was used compared to SMP. Eventhough the main effects of the formulation 
did not indicate any significant difference (p-value 0.9496), the relationship between 
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BMP as a functional ingredient for the protection of probiotics has potential for further 
investigation (Table 3-10).  
Comparing the initial counts in the raw dough to those of the processed RTE 
indicated another interesting trend. Figure 3-15 shows the CFU counts of the raw and 
processed product averaged over formulation and trials for the different probiotics and 
processes. The initial inculcation is consistent at approximately 1x107, while the 
processed bars appear to suffer a one log reduction resulting in post processing counts at 
1x106.  Both of these values are below the level recommended by the National Yogurt 
Board (NYB) at 1x107 (Federal Register 2009).  The initial inoculums were limited in 
cell density, and this was then diluted into the mass of the dough formulation, resulting in 
the low counts. A larger or more concentrated inculcation could lead to a higher cell 
count and sufficient post-processing survival. Most interesting is the relative subtlety of 
the vacuum drying process, despite occurring at elevated temperatures and being a longer 
process. There were no significant differences between the two processing treatments (p-
value 0.83) (Table 3-10). This can also be seen in the survival graph (Figure 3-15) with 
the same count resulting from both methods with all probiotics strains. This would seem 
to indicate that vacuum drying could represent a more cost effective alternative to freeze 
drying for the preservation of a functional RTE food. 
Conclusion  
A novel protein bar formulation has been developed utilizing a high quality dairy 
protein source with the goal of reducing muscle wasting in soldiers and endurance 
athletes. Providing energy dense nutrition in a convenient form is a valid option to deliver 
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the required nutrients necessary to minimize the detrimental effects of undernourishment 
and chronic stress experienced by this demographic. Dairy is considered one of the best 
sources of high quality protein. Dairy provides a complete protein containing all essential 
amino acids, which is critical for nutrition additionally it is high in BCAA which are 
linked to muscle action.  The two formulations that were developed deliver the benefits 
of dairy nutrition in convent energy dense bar (Figure 3-17). The formulation on the left 
utilized only dry conventional ingredients and provides higher protein content than 
initially specified. The formulation on the right was reduced to 75 grams for the purpose 
of the Physiological Validation Study and provided the desired protein content but had 
reduced calorie content.  
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an RTE bar. It results in a final product with good sensory and physical qualities, with a 
crisp texture, sweet mild taste, and very low moisture and water activity levels.  Freeze 
drying has high additional costs and is not common in this segment of the industry 
although it has the potential for large scale manufacturing.  
Many flavors were incorporated throughout the development process (Table 7-1), 
but no profile was finalized. The final formulation resulted in a bar that is mild with a 
light dairy flavor which is a flexible base for further flavoring. This could allow the same 
formulation to be flavored several ways, which was one criterion of military rations.  
Flavoring the bar would require extensive sensory trials; while some preliminary work 
was done, an extensive sensory study would be very useful.  
Probiotics are one of many functional ingredients that could be added to this and 
other RTE bar formulations.  In initial studies we have seen some indication of probiotic 
survival after processing. However, there are other methods for incorporating probiotics 
like sporeforming shelf stable probiotics, encapsulation, and in-bar fermentation that 
could be investigated. Probiotics are of great interest in this type of product mainly 
because of their positive association with gut health and immunity. Other trace nutrients 
and functional ingredients could readily be incorporated into the formulation. Adding 
minerals, vitamins, and high fiber are options that are already on the market and have 
been shown to function in RTE bar formulation.  Finally the development of MPP as a 
viable protein was necessary to achieve the desired protein profile for RTE formulation. 
Its utilization led to a formulation that met the nutritional specifications but without the 
flavor defects seen with WPC.  
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4. MILK PROTEIN PRECIPITATE (MPP) 
Introduction  
Ricotta is a classic Italian style cheese traditionally manufactured from whey. Its 
unique manufacturing process combines high heat and acidification for protein 
precipitation. The process of ricotta cheese manufacturing was used as a model for the 
production of Milk Protein Precipitate (MPP). Precipitating all the protein present in fluid 
milk and using the resulting curd in an RTE bar formulation would deliver high quality 
protein in a convenient and novel form without the negative flavor of dairy powders. 
Using concentrated lactic acid, high heat, and longer holding times results in a soft curd 
(MPP). The mild flavored curd can be used as a nutritional ingredient in further 
processing - a type of industrial cheese. 
The process for the production of MPP was refined in the Dairy Products 
Technology Center (DPTC) and the resulting curd produced a reliable composition 
(Table 4-1). This ingredient was incorporated into the RTE bar formulation to replace a 
portion of the WPC protein. While WPC is the concentration of a small fraction of 
possible milk proteins, MPP was developed to contain a much larger fraction of milk 
proteins. This property makes MPP closer to the intrinsic nutritional value of milk. The 
purpose of creating the MPP was as an experiment to test the possibility of producing a 
high protein product from milk. This protein ingredient was tested using several 
analytical testing methods in order to establish its composition. The functionality of the 
protein ingredient was also tested in the RTE formulation and other products.   
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Table 4-1: Approximate analysis of MPP (n=9) batches. Whole milk ricotta as described by Kosikowski 1982  
Materials and Methods  
The production of Ricotta and Ricotone style cheeses is outlined by Kosikowski 
1982. MPP follows these guidelines and was adopted to create a curd with a significantly 
different nutritional profile (Table 4-1).  The fluid milk is heated to a higher temperature 
before acid addition (180 oF verses 176oF), the pH is reduced further (4.6 versus 6.0-5.9) 
(Kosikowski 1982). Additionally no salt was used in the MPP production process.  A 
holding period at the elevated temperature was also included, this allowed for an increase 
in curd strength.    
Ingredients and Equipment  
 Whole milk, skim milk, whey depending on desired fat content 
 Lactic Acid (88%), diluted to 35% in H2O 
 Portable temperature compensating pH meter, 10mL pipette   
 1.5 L plastic container 
 Large stirring paddle, and scooping device 
Components  MPP Specifications Whole Milk Ricotta 
Protein (N-cube) 25- 27  11.2 
Fat (Babcock) 23-25  12.7 
Moisture (Microwave Drying)  35-40 72.2 
Carbohydrate (Difference)  2-5  3.0  
Ash (Muffle Furnace)  0.75-1.5 - 
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Table 4-3: Compositional analysis of acid and heat coagulated curd (MPP and Ricotta) from either Milk or 
Whey respectively 4/6/10  
Ricotta  Moisture  Protein   MPP  Moisture  Protein   
Non -Pressed 79.86  10.8   Non – Pressed 60.29  21.8  
Pressed  64.22  12.1   Pressed  35.2  27.2  
Approximate Yield  1%  Approximate Yield  11.1% 
 
 
Figure 4-10 is a chart displaying the quantity of acid (35% lactic acid) needed to 
change the pH of milk. Six different MPP productions are recorded to construct an 
acidification chart. Approximately 15ml of 35% lactic acid is needed to acidify one liter 
of raw milk at 50oF. 
 
 
Figure 4-10: Acidification curve of several MPP batches, using 35% lactic acid Raw Milk 
 
Table 4-4 is an approximate analysis of two MPP batches manufactured on 
different days. Fat analysis was conducted using both the Mojonnier and Babcock 
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methods. Protein determination was conducted using the Elementar Rapid-N-Cube. 
Mineral or ash content were determined using a muffle furnace, and moisture content 
using the vacuum oven method.  
Table 4-4: Milk protein precipitate compositional analysis of different batches (values averaged) 
Date Tested 
Sample  
Protein: 
Rabid-N-Cube 
Fat: 
Babcock 
Ash:  
Combustion 
%MC: 
Vacuum oven  
4.13.10 23.4 22.87 1.095 43.17 
4.22.10 25.81 27.5 1.23 40.27 
 
Table 4-5 shows the results of the protein analysis of different MPP productions; 
the production method was kept consistent.  
 
Table 4-5: Protein content of different MPP batches, results done in multiples using Rapid-N-Cube 
Date Performed  Sample  Percent Protein  
4.30.10 MPP 24.76 
5.02.10  MPP 24.61 
5.13.10 MPP 20.84 
5.27.10 MPP 27.44 
5.28.10 MPP 26.61 
 
Figure 4-11 is an urea gel depicting the protein profiles of several samples related 
to MPP production. MPP’s starting ingredient milk (well one), the residual liquid (well 
2), and the MPP protein from two manufacturing dates (wells 3 and 4). These are in 
contrast to cheddar cheese and cheddar whey (wells 5 and 6). Well 7 shows the protein 
profile of the RTE bar compared to that of a competitor (well 8), and WPC (well 9).      
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ricotta; this contains a much lower protein content than milk (0.9% versus 3.4%). After 
precipitation the final protein content of the two residual liquid streams are similar, with 
the MPP registering lower (0.4 verses 0.55%) (Table 4-2). The greater efficiency at 
removing the total protein from the liquid phase is due to interactions that form between 
the casein and whey protein fractions.  The effectiveness of MPP can also be compared to 
rennet cheese manufacturing. The remaining protein left in MPP residual liquid contains 
approximately 0.45% protein while rennet whey contains approximately 0.9%. Co-
precipitation is achieved by reaching the iso-electric point of casein with the low pH, and 
the whey protein precipitation using high heat.  As a result this process yields a complex 
protein aggregate of both casein and the whey proteins (α-lactalbumin, β-lactoglobulin) 
while the single precipitation of whey forms a more simple fragile curd.  
This co-precipitation has a large impact on the resulting curd produced, increasing 
the protein content and reducing the moisture (Table 4-3). The higher protein content and 
yield that is seen with the MPP is due to higher initial protein in milk (Kosikowski 1982). 
However the lower moisture that is seen results from the syneresis that occurs in the co-
precipitated protein aggregates during the hold time. The residual liquid is expelled as the 
proteins hydrophobic regions bind, however in ricotta this is not as significant. To further 
reduce the moisture content and increase the protein concentration the curd was pressed.   
Pressing was defined as placing the curd in a Gouda cheese hoop under a 10lb weight for 
two hours, and Non-Pressed as the curd left to drain in a plastic basket for two hours. 
This additional step reduced the curd moisture 42% in the MPP versus 20% with ricotta.  
This again results from the co-precipitation where the aggregates have less moisture most 
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of which is easily removed, while the whey ricotta has lower solids and a greater amount 
of residual liquid that is incorporated into the curd during precipitation.    
The acidification of MPP is an integral step in the co-precipitation of the dairy 
protein. Acidification is also an important step in heat precipitated cheeses. However, 
acidification has a more significant role in MPP manufacturing than in ricotta.  Acetic 
and citric acid are commonly used in the manufacturing of ricotta, but result in distinctive 
flavors in the curd.  Lactic acid produced by inoculated starters results in a milder 
flavored curd and is the recommended acidulate for whole milk ricotta (Kosikowski 
1982). Hence, 35% lactic acid solution was used in the MPP manufacturing process 
which allowed for quick and consistent acidification of the milk (Figure 4-10). While 
day-to-day variability would exist in the production of MPP, a use level of approximately 
14-16ml of 35% lactic acid is necessary to acidify one liter of milk. This value could be 
used to create a standard manufacturing procedure for MPP.   
The composition of MPP is detailed in the approximate analysis of two separate 
batches manufactured on two dates (Table 4-4). These two batches fit within the range of 
the MPP specifications outlined in Table 4-1. While the composition of the two batches 
shows variability, it is apparent that a similar ingredient is produced. Larger variability is 
possible, as is seen in Table 4-5 where the protein content ranges between 20% and 27% 
across five separate batches. This large range is due to the handmade batch processes 
used to make this product.  Many factors could influence the protein content of the final 
product and not all can be controlled without proper mechanization of the process. Poor 
efficiency during initial curd removal could lead to higher residual moisture; improper 
acidification and heating would lead to less complete protein precipitation. Many 
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additional factors would influence this bottom line, however industrial production would 
greatly limit this variability.    
MPP was developed to deliver a high protein curd with a composition identical to 
that of milk and dairy proteins. The MPP would then be utilized as an ingredient to 
deliver this protein to the consumer in the form of a RTE bar. A urea electrophoresis gel 
was prepared using selected protein fractions (Figure 4-11). This gel illustrates the 
potential for the RTE bar to have the same physiological effects as dairy when MPP is 
used.  The urea gel is able to visually demonstrate the change in protein through 
processing. Well 1 is the protein profile of milk, which demonstrates the complexity of 
the RTE protein target. Wells 3 and 4 both contain MPP protein and show similar profiles 
when compared to the original milk sample. Additionally, looking at the profile of the 
resulting whey can give an indication of what proteins were not precipitated. Looking at 
well 2 which contains the whey left over after MPP processing, the profile looks similar 
to the MPP itself. This is a striking difference from the profile of cheddar cheese whey in 
well 5 and curd in well 6. This is because the processing of the MPP is designed to 
precipitate more total protein from the milk, thus resulting in a curd with a more 
“complete” profile. The protein profile of WPC in well 9 shows no distinct bands or 
pattern. This is due to the processing methods of WPC which subject the proteins to 
thermal and mechanical degradation.  The “complete” protein profile is preserved 
through the processing of the RTE bar (well 7) with a protein profile almost identical to 
MPP used in its manufacturing.  
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Conclusion 
MPP delivers the positive nutritive value of milk protein, and represents an 
alternative method of incorporating dairy in products beyond powders and fluid milk.  
This ingredient is manufactured using high heat (190oF) and low pH (4.6), which results 
in a complete precipitation of both whey and casein proteins. MPP exhibits excellent 
functional properties and provides added nutrition in the RTE bar and other products.  
The MPP can aid in the structure and binding of formulations in a similar way to HFCS 
or wheat gluten.  MPP can additionally be used to simplify product formulations since it 
incorporates fat, moisture and protein.  MPP can also serve as a binder and/or bulking 
ingredient in a bar or yogurt, while having the added benefit of being derived from dairy. 
In order to ensure that its functionality and potential is realized, MPP would require 
further work, particularly concerning shelf life and storage. As a fresh, un-aged cheese 
with high moisture MPP has little hope of a commercially viable shelf life. Post 
processing contamination is the major factor that compromises the stability of this 
ingredient. The addition of preservatives or the utilization of aseptic packaging or 
freezing could extend the shelf life but further development is necessary. Overall, MPP 
has the added benefit of being derived from dairy and being perceived as a natural 
ingredient.  
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5. PHYSIOLOGICAL VALIDATION OF RTE STUDY 
Introduction  
The benefit of supplemental protein for sports recovery is a current and highly 
debated topic. Proponents point to the anabolic effect of dietary protein and the improved 
energy-balance gained from consuming protein post exercise. Opponents hold that the 
total caloric energy and the metabolic ease that carbohydrates offer are more important 
for recovery (Jentjens et al. 2001). It has been suggested that active individuals require 
greater amounts of protein than the RDA (Anonymous 1997). These excess amounts are 
at 50-100% compared to their sedentary counterparts (Lemon 1987). The development of 
the high protein RTE bar was based on the former premise, aiming to deliver protein in a 
calorically dense dietary supplement. The hypothesis for this study is that providing 25 
grams of dairy-derived protein post exercise would improve body composition measured 
by weight and body fat and reduce inflammation and physiological stress markers 
measured in the blood. The purpose of the blood markers was to compare the 
physiological effect of the treatment bars on post exercise recovery.  
Blood Markers  
The following five blood components were selected as markers for this study for 
their correlation with inflammation and metabolism: 
1)  Erythropoietin (EPO): A hormone involved in the production of red blood cells. It is 
also responsible for promoting neuronal survival after hypoxia  and other trauma (Sirén et 
al. 2001). EPO is involved in the biological signaling of the brain and nervous system and 
has also been associated with cellular proliferation.  
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2)  Hydrocortisone (Cortisol AM): Cortisol levels can serve as an indicator of 
hypothalamus pituitary adrenal axis (HPA) activity, which is involved in neurological 
stress responses. Fluctuations in individual cortisol levels are also associated with 
perceived stress (Wust et al. 2000).  
3)  C-Reactive Protein (CRP): A protein whose concentration in the blood is 
directly related to the immune system response to tissue injury, infection, and a key 
inflammation marker. CRP level’s are routinely tested when evaluating human diseases 
and are associated with the immune system  (Thompson et al. 1999). CRP is synthesized 
by the liver in response to factors released by fat cells adipocytes (Pepys and Hirschfield 
2003). 
4)  Creatine Phosphokinase (CPK):  An enzyme responsible for the reversible conversion 
of ATP to ADP. CPK is said to function as an energy transporter, delivering the energy 
from the site of production to that of utilization. CPK is also said to have a buffering 
capacity, functioning like an energy storage mechanism (Wallimann and Hemmer 1994). 
5)  Adolase: An enzyme involved with fructose metabolism which can be correlated to 
the dietary intake of carbohydrates (Munnich et al. 1985).  
In this study, paid subjects performed strenuous hikes on three consecutive days, 
which were repeated after a one week rest period. The subjects hiked specified routes 
carrying 20% of their body weight in backpacks. The physical activity prescribed was 
designed to mimic military combat situations where physical and mental stresses are 
high. The participants were split into two teams which competed for speed and tactical 
points. A single blind cross-over design was implemented with subjects receiving one 
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treatment bar after completing each hike during the first test period and the other bar 
through the course of the second test period.  
Subjects and Methods  
Participants 
Recruitment was open to all Cal Poly students but focused on the regional ROTC, 
wrestling, cross country, and swim teams. The subjects were all young and athletic 
between 18 and 30 years of age. Subjects were screened for milk allergies and other 
medical conditions and asked to fill out Physical Activity Readiness Questionnaire (PAR-
Q) forms and Subject Information Forms for legal compliance. The study was approved 
by the Cal Poly Human Subjects Board and the participants were informed of the 
potential risks involved in the study. The subjects were told not to control their diet or 
exercise routines for the purposes of the study but were asked to fill out diet logs for the 
dates involved. On the night before each test period (5/20/10 and 6/03/10), the subjects 
were invited to a free carbo-loading dinner. This also served as an orientation session 
where the researchers were available to answer questions and provide information on the 
study.      
Protocol  
The study consisted of two three-day test periods, separated by a one week rest or 
wash-out period. The two test periods consisted of three consecutive days of strenuous 
hikes, chosen for their length (between 6 and 8 miles) and difficulty (topographical 
images are available in the appendix page 114). Each complete test period was 
considered a treatment, with one team being administered the test bar and the other team 
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the control bar. On the first day of the test period (5/21/10, 6/04/10), subjects went to the 
University Health Center to have baseline blood draws and have their weight and percent 
body fat determined.  The subjects’ body weight was recorded and used to calculate their 
“carrying load” which was to be used during the test period hikes. Each subject was 
required to carry 20% of their body weight which included their backpack, super soaker, 
and water bottle. The remaining carrying weight was reached using sand bags. Each 
subject was provided a 32oz sports bottle filled with lemon and lime Gatorade during 
each hike.       
On the mornings of the test periods, subjects met at 11 am in the Kinesiology 
department building. The subjects joined their respective teams and were given their 
water filled super soaker and sports bottle. When the subjects were ready, one team 
which alternated started first and was followed 15 minutes later by the second team. A 
“medic” was assigned to follow behind the last subject and was responsible for picking 
up garbage, carrying a cell phone, attending to minor injuries, and carrying additional 
water.  As the subjects completed the hikes, they were given their corresponding 
treatment bar and water was made available. The subjects were asked to completely 
consume the bars. After finishing their respective bars, the subjects completed an 
anaerobic power test, a “30 second Wingate”, and their post hike choice reaction test. 
They were then were free to go. This process was completed on each of the three days 
during the test period.   
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Response Variables  
Body Composition:  Measured by static and underwater weighing Friday (5/21, 
6/04) and Sunday (5/23, 6/06). Response reported as change between Sunday and Friday 
measurements.  
Simple Choice Reaction: Time to respond (lift corresponding finger) to a light 
stimulus, measure before and after each hike. Response reported as daily change between 
after and pre hike reaction time.  
Blood Draws: Samples taken on Friday (5/21. 6/04) and Monday (5/24, 6/07). 
Response reported as change between Monday and Friday blood draw.  
Peak Power: Measured as highest mechanical power (Watts = Force x Distance) 
generated during the first 5 seconds of a 30 second Wingate Test. Measured after each 
hike, response reported as daily peak power.   
Experimental Design  
The experiment followed the simple cross-over design (Woods et al. 1989) 
common in small scale medical studies. The study intended on being single blind, with 
the teams receiving one of the two treatment bars unknown to them. The initial group of 
subjects (n=36) contained two females and thirty-four males. On the first day of the study 
(5/21/10), the group was randomly separated into two teams, either “Green” or “Gold” by 
the flip of a coin. One female from the Gold team was moved to the Green team to 
balance the sex ratio between teams. The resulting teams, Gold (n=17) and Green (n=19), 
were given colored t-shirts. During the first test period (5/21 – 5/23/10) the Gold team 
was given the test bar and the Green team the control bar, this was decided by a coin toss.  
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during the first period had lingering effects into the second period. This can be avoided 
through a long flush out time and by using treatments without lingering effects. The 
following statistical model was used to test for treatment effects and possible carry-over 
effects: 
Equation 5-1: Two-stage model adapted from (Shen and Lu 2006) 
Yijk =μ + bij + πk + Фm + λm + ξijk    
i=treatment order, j=subject, k= week, m= treatment  
μ= overall mean 
bij = effect of jth subject with ith order and is ~N(0,σb2)  
πk = effect of the kth week 
Фm = direct effect of the mth bar treatment 
λm = lingering effect of the mth bar treatment  
ξijk = random error and is ~N(0,σb2) 
 
 
Table 5-1: Summary of effects influencing response in weeks, adapted from (Shen and Lu 2006). 
Team Bar Order  Week 1 Week 2 Sum Difference  
Gold  Test-Control μ + π1 + Ф1 
(Y1.1) 
μ + π1 + Ф2 + λ1 
(Y2.2) 
Y1.1  + Y2.1 Y1.1  - Y2.1 
Green Control-Test μ + π1 + Ф2 
(Y1.2) 
μ + π1 + Ф1 + λ2 
(Y2.2) 
Y1.2  + Y2.2 Y1.2  - Y2.2 
 
If a carry-over effect is considered significant, the data analysis should not 
include the second test period as the results would be influenced by the first week. This 
test was performed by comparing the sums of the two teams’ total responses, which only 
differ by the order of the treatments. This is expressed as the null hypothesis H0: λ1 = λ2, 
which if rejected indicates a significant carry-over effect.   
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Equation 5-2: Null hypothesis for carry-over effect, proof and simplification adopted from Shen and Lu 2006).     
H0:  Y1.1  + Y2.1 = Y1.2  + Y2.2  
H0:  μ + π1 + Ф1 + μ + π1 + Ф2 + λ1 = μ + π1 + Ф2 + μ + π1 + Ф1 + λ2 
H0: λ1 = λ2 
 
The treatment effect is calculated only if the null hypothesis for the carry-over 
analysis is not rejected. A treatment effect is interpreted as one bar having a significantly 
different effect on the response variable when compared to the other bar, regardless of the 
order.  This test was performed using the difference between the two teams’ total 
responses multiplied by a constant factor to eliminate all other interfering components.  
This is expressed as the null hypothesis H0: Ф1 = Ф2 which if rejected would indicate that 
the direct effects of the bar treatments were not equal.  
Equation 5-3: Null hypothesis for treatment effect, proof and simplification adopted from (Shen and Lu 2006).     
H0: ½( Y1.1  - Y2.1) = ½(Y1.2  - Y2.2) 
H0: ½( μ + π1 + Ф1 - μ - π1 - Ф2 - λ1) = ½(μ + π1 + Ф2 - μ - π1 - Ф1 - λ2) 
H0: Ф1 – ½ λ1 = Ф2 – ½ λ2    ( λ1 = λ2 if no carry-over exists)  
H0: Ф1 = Ф2  
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Treatment Bars  
Table 5-2: Nutritional composition comparison between treatment bars 
Component        Test Bar 
“High Protein RTE” 
Control Bar  
“First Strike” 
Total Calories 290 kcal 250 kcal 
   Fat Calories 120 kcal 50 kcal 
Protein 25 g 3.0 g 
Carbohydrate 16 g 47 g 
Dietary Fiber    -                  2 g 
Fat 14 g 6 g 
   Saturated Fat 9 g 1 g 
   Polyunsaturated Fat - 3 g 
   Monounsaturated Fat - 1 g 
Cholesterol 30 mg 0 mg 
Sodium 330  mg 75 mg 
Total Weight 75 g 65 g 
 
The test bar was the RTE Bar formulated and described in Chapter 3. The control 
bar was the “First Strike Cran-Rasberry”, currently supplied in government issue Meals-
Ready-to-Eat MRE First Strike rations. The nutrition labels are presented in the appendix 
(Figure 7-5). The nutrition panels are available in the appendix (Figure 7-4). The First 
Strike bars were donated by Alexius International, Inc, Fresno Ca. One hundred and 
twenty First Strike bars were randomly selected from a box containing over five hundred. 
These bars were removed from their retail wrapping and then placed inside the same 
laminate bags as the RTE bars and placed in a refrigerator.  The Test bar (RTE) was 
produced in-house following the method described in Chapter 3.  The bars were tested for 
microbial and compositional specifications (Table 7-6).  The bars were packaged in 
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laminated pouches and stored in a refrigerator until used.  The RTE bars used in this 
study contain the MPP protein described in Chapter 4, and the resulting curd was also 
analyzed for adherence to microbial and compositional specifications available in the 
appendix (Table 7-4).  
Results      
Statistical analysis for the carry-over and treatment effects revealed no significant 
differences; all p-values were greater than 0.05 (Table 5-3). This indicates that no carry-
over effect between the test periods exists. In addition, the chosen blood markers were 
not affected differently by the treatment bars.   
Table 5-3: Mann-Whitey p-value results for blood markers 
Blood Marker 
Response 
Carry-Over Effect 
p-value 
Treatment Effect 
p-value 
Erythropoietin 0.90 0.21 
Hydrocortisone 0.12 0.12 
C - Reactive Protein 0.64 0.08 
Creatine Phosphokinase 0.06 0.36 
Adolase 0.13 0.92 
 
Body composition data for the different teams reveal that they were not well 
balanced. The mean weight for the Gold team throughout the study (182lbs) was 
approximately 14lbs greater than that of the Green team (167lbs) (Table 5-4). The Gold 
team also had a 3% greater body fat. Both team lost body fat and total weight on average 
every test period, except the Green team in week 1. Variability appears to be greater in 
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the test period changes of the Gold team; this is indicated by the larger standard deviation 
(Table 5-4).   
Table 5-4: Summary of body composition measurements over the course of the study (wt in Lbs).   
Week  Team  Bar Measurement  Friday 
Mean  
Monday 
Mean  
Mean 
Change 
Standard 
deviation  
1 Gold Test Weight  181.8 181.1 -0.7 2.4 
   Fat percent  17.6 16.0 -1.5 3.5 
1 Green Control Weight  166.6 167.6 1.0 1.8 
   Fat percent  14.5 12.7 -1.7 2.6 
2 Gold Control Weight  181.7 180.0 -1.8 3.6 
   Fat percent  17.6 16.0 -1.5 3.5 
2 Green Test  Weight  167.6 167.0 -0.6 2.2 
   Fat percent  14.5 12.7 -1.7 2.6 
Erythropoietin (EPO) 
On first examination of the mean EPO concentration (Table 5-5), the values 
appear to be very similar, even across the test periods. The mean concentration for the 
Gold team using the test bar was 8mU/mL while the Green team with the control bar was 
9mU/mL   (Table 5-5). The variability becomes evident in the mean and median changes 
between the dates. For example, the mean change for the Gold team with the test bar was 
-0.47, while the Green team with the test bar was 0.65.  
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Table 5-5: Summary of blood analysis results for EPO - Range 4 - 27 mU/mL. 
Week Team Bar 
Friday 
Mean 
Monday 
Mean 
Mean 
Change 
Median 
Change 
Standard 
Deviation  
1 Gold Test 8 8 -0.47 0 3.30 
 Green Control 7 8 0.65 1 2.64 
2 Gold Control 8 9 1.76 3 3.46 
 Green Test 8 9 0.65 1 3.66 
 
Besides the p-value for EPO, the mean effects table and graphs can be used to 
interpret the direction and trend of the results (Table 5-6). In both weeks the test bar had a 
lower mean change, despite week 2 having a higher overall response. This is also 
confirmed by the fact that both Green and Gold teams had the same total treatment effect 
of 1.3, indicating that the order of the treatment had no effect on the resulting blood 
response. 
Table 5-6: EPO summary of effects table, values are the mean difference for the test period. 
 
 
 
 
This trend can be quickly visualized from the main effects plots (Figure 5-2): the 
test bar having a lower mean and week 2 having a higher overall mean difference.  
 Gold Green Totals  
Week 1 Test: -0.5 Control: 0.6 0.2 
Week 2  Control: 1.8 Test: 0.6 2.4 
Totals  1.3 1.3  
             Treatment Difference (Test - Control):    -2.2 
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Figure 5-2: Main Effect Chart of Bar type and Week on EOP concentration 
Cortisol AM 
Three out of the four (team-bar) combinations resulted in a decrease between the 
baseline and treatment blood draws (Table 5-7). Additionally, the increasing combination 
(Gold-Test) has the highest mean/median change and standard deviation. This one 
combination contributed to the lack of treatment effect.  
Table 5-7: Summary of blood analysis results for Cotisol AM - Range 6.2 - 19.4 ug/dL. 
Week Team Bar 
Friday 
Mean 
Monday 
Mean 
Mean 
Change 
Median 
Change 
Standard 
Deviation  
1 Gold Test 15.1 18.4 3.26 3.30 7.36 
 Green Control 16.8 16.4 -0.40 -0.90 5.41 
2 Gold Control 18.1 16.9 -1.18 -0.30 5.06 
 Green Test 16.5 16.0 -0.48 -1.60 4.56 
 
Cortisol AM resulted in a nearly significant carry-over effect (Table 5-3) with a p-
value of 0.11. The cause of this can be seen from the lack of a pattern in the summary 
table (Table 5-8): in week 1 the test bar resulted in a larger mean difference, in week 2 
the test bar had a lower mean difference. The total response for the Green and Gold teams 
is significantly different (2.9 for Gold and -1.7 for Green). The total response each week 
is also significantly different, with week 1 having a far greater response versus week 2  
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(2.1 and -0.9). These large discrepancies indicate that the order of treatment might have 
an effect on the response.   
Table 5-8: Cortisol AM summary of effects table, values are the mean difference for the test period 
 Gold Green Totals  
Week 1 Test: 3.3 Control: -1.2 2.1 
Week2  Control: -0.4 Test: -0.5 -0.9 
Totals  2.9 -1.7  
           Treatment Difference (Test - Control):     4.4 
 
A basic trend, while not statistically significant, does exist and can be seen in 
(Figure 5-3). The test bar results indicate a higher response compared to the control bar; 
the total response was greater for the first week compared to the second.  
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Figure 5-3: Main effect chart of Bar type and Week on Cortisol AM concentration 
C - Reactive Protein (CRP) 
The individual mean values and mean change show a trend where CRP increases 
after the treatment period. The mean change and standard deviation for the Green team in 
week 1 was significantly greater than the other combinations. This spike reduces the 
ability to detect a trend. 
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Table 5-9: Summary of blood analysis results for CRP AM - <1.0 low, >3.0 High 
Week Team Bar 
Friday 
Mean 
Monday 
Mean 
Mean 
Change 
Median 
Change 
Standard 
Deviation 
1 Gold Test 1.9 2.9 1.05 0.90 0.74 
 Green Control  2.6 2.1 -0.48 0.40 6.01 
2 Gold Control  1.2 2.0 0.76 0.40 2.21 
  Green Test  1.0 1.9 0.94 0.60 1.13 
  
The effect of the bars from week and treatment order can be seen by comparing 
the mean values (Table 5-10). The test bar results show a higher mean difference for both 
weeks, independent of the order in which they were taken (1.0 verse -0.5) and (0.9 verses 
0.8).  However the total response for the teams is very different (1.5 verses 0.5), which 
could indicated an effect of the team.  
            Table 5-10: CRP summary of effects table, values are the mean difference for the test period 
 Gold Green Totals  
Week 1 Test: 1.0 Control: -0.5 0.6 
Week 2  Control: 0.8 Test: 0.9 1.7 
Totals  1.8 0.5  
           Treatment Difference (Test - Control):   1.7 
 
The variability within the results is very evident in the main effects plots (Figure 
5-4). The test bar resulted in a much smaller spread of data compared to the control, as 
did week 2.  The p-value from the Mann-Whitney test (Table 5-3) indicates CRP as 
having the closest to a significant treatment effect at 0.076, with the test bar causing a 
greater response.   
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Figure 5-4:Main effect chart of Bar type and Week on CRP concentration 
Creatine Kinase (CPK) 
The individual mean results display the source of the variability seen in the CPK 
results. The “Monday” mean for the Gold team in week 1 is 1129 U/L which is 
significantly greater than the other mean values (260-614 U/L) (Table 5-11). The 
resulting mean change and standard deviation for that combination are also much greater 
than the trend set by the other dates.   
Table 5-11: Summary of blood analysis results for CPK - Range 35 - 104, U/L 
Week Team Bar 
Friday 
Mean 
Monday 
Mean 
Mean 
Change 
Median 
Change 
Standard 
Deviation 
1 Gold Test 270 1129 858.47 423.00 1030.18 
 Green Control  222 614 391.35 287.00 326.43 
2 Gold Control  208 374 165.94 112.00 208.23 
  Green Test  274 260 -14.12 33.00 330.48 
 
 
CPK results indicated the most significant carry-over effect, with a p-value of 
0.063. The source of this can be seen by comparing the mean differences with the test bar 
results having a higher mean difference in the first week (858.5 U/L versus 391.4 U/L) 
and a lower difference in the second week (-14.1 U/L versus 165.9 U/L). The totals for 
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the teams are also very different, which could be due to the effect of the treatment order 
or team.  In addition, “week” appears to have a significant effect on the results where 
week 1 resulted in a higher mean difference than week 2.  
Table 5-12: CPK summary of effects table, values are the mean difference for the test period 
 Gold Green Totals  
Week 1 Test: 858.5 Control: 391.4 1249.8 
Week 2  Control: 165.9 Test: -14.1 151.8 
Totals  1024.4 377.2  
Treatment Difference (Test - Control):  287.1 
 
The resulting large variability and lack of general direction can be seen in the 
main effects plots (Figure 5-5). The test bar appears to have a higher response; this is 
shadowed by the large variability in the test sample.  Week 2 has less variability and a 
lower response.   
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Figure 5-5: Main effect chart of Bar type and Week on CPK concentration 
Aldolase 
The individual mean responses appear to be separated by week, with week 1 
resulting in greater changes than week 2 (Table 5-13).  This is true for both treatments 
and both teams; the variability measured by the standard deviation appears relatively 
consistent between combinations.  
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Table 5-13: Summary of blood analysis results for Adolase - range 1.5 - 8.1, U/L 
Week Team Bar 
Friday 
Mean 
Monday 
Mean 
Mean 
Change 
Median 
Change 
Standard 
Deviation 
1 Gold Test 6.4 11.3 4.91 2.60 4.47 
 Green Control  6.8 10.2 3.39 3.20 2.77 
2 Gold Control  4.9 5.6 0.72 1.10 1.89 
  Green Test  6.6 5.6 -0.94 0.50 4.44 
 
Aldolase resulted in the least significant treatment with a p-value of 0.91 and a 
close to significant carry-over effect of p-value 0.13 (Figure 5-3). The lack of a treatment 
effect can be seen in the similarity between the mean differences; the test and control bars 
had the same response in week 2 and very similar values in week 1. The test bar resulted 
in a slightly higher response in week 1 and the same response in week 2, which might 
indicate an order effect. 
       Table 5-14: Aldolase summary of effects table, values are the mean difference for the test period 
 Gold Green Totals 
Week 1 Test: 4.9 Control: 3.4 8.3 
Week 2  Control: 5.6 Test: 5.6 11.3 
Totals  10.5 9.0  
Treatment Difference (Test - Control):   1.5 
 
The variability within the test bar treatments’ results is much greater than that of 
the control bar. However, their mean values appear quite similar indicating no treatment 
effect (Figure 5-6). The weeks have a similar level of variability with week 1 having a 
larger mean response than week 2. 
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Figure 5-6: Main effect chart of Bar type and Week on Aldolase concentration 
Discussion  
The data indicated that generally an increase in the particular blood component 
occurs over the course of test period (Table 7-3). An increase over the test period 
indicates inflammation has occurred as a result of the physical treatment.  An increase in 
blood marker concentration occurs a majority of the cases, in some instances there is a 
decrease in one or both weeks. This factor contributes to the variability in the statistical 
analysis, and is likely caused by confounding factors.  
Outliers were considered a potential problem in the initial analysis of the data. 
Conventional statistical analysis using either GLM or t-test models could not be applied 
because of lack of normality in several of the blood marker responses. One proposed 
solution was the removal of potential outliers which would cause the data to fit the 
normality assumption. A small survey of the data revealed that this would not be 
practical. 
Table 7-2 in the appendix summarizes outliers defined as values greater or less 
than two standard deviations from the mean. The number of individual considered as 
outliers from this comparison was significant, the outliers were not consistent across 
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markers or blood draws.  The outliers and the naturally large variability in the data led to 
the use of the non-parametric analysis tool Mann-Whitney.  
As mentioned earlier, the possibility of a carry-over effect is one of the major 
complications with a cross-over experimental design (Woods et al. 1989). The possibility 
of this type of influence is significant in drug and therapeutic exercises where the 
treatments have lingering effects. An estimated washout period of 5x the half-life of the 
treatment has been recommended for crossover experiments (Shen and Lu 2006). The 
treatments used in this study are macronutrients (protein, carbohydrates) which are 
normally consumed by the individuals. Considering the regular digestion time for most 
individuals, the one-week rest period should have exceeded these recommendations. 
While there appears to be some indication of a carry-over effect in some markers, it is 
more likely that the “team” and “week” had an influence on the response. In every blood 
marker the “week” greatly affected the magnitude of the response. While this was not a 
treatment, and all factors were purposely kept the same, the response appeared to be 
influenced.  Other factors could exist namely weather differences, motivational and 
learning changes, and external stressors. These factors might have had an influence over 
the markers in an unpredictable way.  
The results from the Erythropoietin (EPO) analysis did not indicate a carry-over 
effect (Table 5-3) with a p-value 0.904. The role of EPO in the body as an indicator of 
red blood cell production could signal muscle anabolism as well as physical trauma 
(Sirén et al. 2001). The trend in the main effects plots (Figure 5-2) indicated that EPO 
levels increased more with the control bar than the test bar. This could be interpreted as 
the result of the control bar increasing blood production in response to the physical 
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damage of the test period. It could also indicate that the test bar provided a physiological 
buffer in repairing damaged muscle, which reduced the “exaggerated” response of the 
control bar.  
Subjects were allowed to schedule their after treatment (Monday) blood draw at 
their convenience during the open hours of the University Health Center (8am-4pm). This 
factor could have influenced the response of some blood markers. Cortisol levels are 
greatly affected by time, with increases seen most dramatically 30 minutes after waking 
up (Wust et al. 2000). This natural fluctuation in the concentration could lead to treatment 
effects being ignored. Requiring all subjects to return at the same time for each blood 
draw may have avoided some of the in-subject variation.  Cortisol AM was close to 
causing a carry-over effect with a p-value of (0.12) (Table 5-3). This is likely due to 
cortisol time dependence instead of an actual lingering effect. The main effects trend 
indicated that the test bar results had higher levels of cortisol, which is an indicator of 
stress. However, there was no statistical support for this trend.   
C - reactive protein (CRP) had the lowest p-value of any tested marker (0.076) 
and no indication of a carry-over effect (0.64) (Table 5-3).  CRP levels appeared to be 
higher when the subjects used the test bar versus the control bar. CRP levels increase 
after the test period in all instances except “Green Team - week 2”, (Table 7-3).  CRP is 
related to inflammation and the body’s response to physical damage (Thompson et al. 
1999). This increase is justified by the inflammation that would have occurred as part of 
the physical activity during the test period. The main effect plot of the CRP (Figure 5-4) 
shows the previously stated trend, but in addition, much greater variability in the control 
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bars’ results. This variability was caused by one individual outlier (Table 7-2) and only in 
“week 1”, which might have been caused by an acute and unreported illness or injury.  
Creatine phosphokinase (CPK) is the only marker which could be said to have a 
carry-over effect. While the p-value (0.062) was greater than the preset alpha value of 
0.05 there is an increase possibility for week 2 values to be influence by week 1. The 
mean difference results (Table 5-12) indicates a large difference in means between 
weeks, week 1 resulting in significantly greater response then week 2, (1250 verse 150). 
In addition, order of the treatment bar appears to have an effect. In week 1 the test bar 
resulted in a greater response and in week 2 the response was lower than the control. This 
fluctuation in the results is likely due to the natural variability of this marker. There are 
also a large number of outliers (Table 7-2) for this marker.  This would indicate that CPK 
is unaffected by the treatment, despite the trend that is seen in the main effects plots 
(Figure 5-5), but heavily affected by week.   
Adolase levels are directly related to diet, underfeeding can reduce levels while 
carbohydrate-rich diets can quadruple levels (Munnich et al. 1985).  Our results indicated 
no significant difference between the treatment bars with a p-value of 0.99. This could be 
interpreted as neither group being underfed carbohydrates during this study. This 
indicates that the reduced carbohydrate content in the test bar did not lead to any 
deficiency in carbohydrates for either team.  
The body compositional data did not yield any meaningful trends that could 
indicate any weight or body fat losses associated with either treatment bar. This could 
have been caused by a lack of balance or subject pairing between the teams.  Three 
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subjects who had a weight over 200lbs were randomly placed in the Gold team.  The 
effect of this is evident from the Gold team having a greater body fat percentage (17.6% 
versus 14.5%) on the first Monday and being on average 14lb heavier throughout the 
study. Both teams lost more weight during the second week of the study; while the Green 
team actually gained one pound in weight during the first period. Both teams lost the 
same amount of body fat in each period, which indicated no effect of week or treatment 
on body fat level.     
Conclusion  
This preliminary study showed that none of the selected blood markers showed 
significant differences among the treatment bars over the course of the study. Individuals 
did not show any signs of improvements or under-nourishment from either bar. While 
there are no statistical correlations, some trends are apparent. EPO levels decreased, CRP 
levels increased and Adolase levels appear unaffected by test bar consumption. The lack 
of statistical support for these trends is due to the variability in the results, which is 
caused by: small sample size (n=34, 17 each treatment), short test period, team balancing, 
and subject controls.   
The experimental design could be improved to produce more tangible results.  
The first priority would be a larger sample size, with a minimal of 30 individuals per 
treatment group, which would allow for the identification of smaller differences between 
the treatments. Diet and exercise controls for the subjects could help to reduce the 
outliers seen in this study. As a method of reducing variability, the diets and exercise of 
the subjects can be controlled so that all groups receive the same calories and physical 
 
 
100
activity outside of the treatment period.  A longer experimental period could also help to 
distinguish the treatment effects. A longer exercise period could lead to more significant 
exhaustion, inflammation, and muscle catabolism which is what the RTE bar was 
developed to reduce. Another factor influencing the response is the time of the post-
treatment blood draw. This occurred at earliest eighteen hours after the end of the 
treatment period, this time might have already reduced the inflammation response.  The 
cross-over design and Mann-Whitney test were effective in the analysis of this study. 
However more subjects would allow for a randomized complete block design and more 
traditional ANOVA and GLM statistical analysis.   
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Dry Buttermilk (DBM) 
Production Definition 
Dry Buttermilk is obtained by drying liquid buttermilk that was derived from the 
churning of butter and pasteurized prior to condensing. DBM has a protein content of not less 
than 30.0%. It may not contain, or be derived from, nonfat dry milk, dry whey or products other 
than buttermilk, and contains no added preservative, neutralizing agent, or other chemical. DBM 
for human consumption complies with all provisions of the U.S. Federal Food, Drug, and 
Cosmetic Act. 
Other Characteristics 
Scorched Particle Content2.................................................... 7.5 – 15.0 mg 
Titratable Acidity2 ................................................................. 0.10 – 0.18% 
Solubility Index...............................< 1.25 ml – spray process< 15.0 ml – roller process 
Color2 .................................................................................uniform cream to dark cream 
Flavor2 ................................................................................... clean and pleasing 
Ingredient Statement 
“Dry Buttermilk” 
Production Applications and Functionality 
Bakery products, frozen desserts, prepared dry mixes, beverages, cheese products, frozen foods, 
dairy products, salad dressings, snack foods 
Storage & Shipping 
Product should be stored and shipped in a cool, dry environment with temperatures below 80°F 
and relative humidities below 65%. Stocks should be rotated and utilized within 6 to 9 months. 
Packaging 
Multiwall kraft bags with polyethylene inner liner or other approved closed container. (i.e. “tote 
bins,” etc.) 
Typical Compositional Range1 
Percentage 
Protein2 .............................. > 30.0 – 33.0 
Lactose...................................46.5 – 49.0 
Fat2 .............................................4.5 – 7.0 
Ash.............................................8.3 – 8.8 
Moisture2....................................3.0 – 4.0 
Microbiological Analysis 
Standard Plate Count2 ................< 20,000/g 
Coliform............................................< 10/g 
Salmonella .................................... negative 
Listeria .......................................... negative 
Coagulase-positive 
Staphylococci............................. negative 
_____________________________________ 
1 On an “as is” basis 
2 USDA Grade parameters (7 CFR §58.2654) 
-5- 
Specification 4: Butter Milk Powder 
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Nonfat Dry Milk (NDM) 
Production Definition 
Nonfat Dry Milk is obtained by the removal of water from pasteurized skim milk. It 
contains not more than 5% moisture (by weight) and not more than 1.5% milkfat (by weight) 
unless otherwise indicated. NDM for human consumption complies with all provisions of the 
U.S. Federal Food, Drug, and Cosmetic Act. 
Other Characteristics 
Scorched Particle Content2.................................................... 7.5 – 15.0 mg 
Solubility Index2..................................................................<1.2 ml < 2.0 ml – high-heat 
Titratable Acidity2 ................................................................. < 0.15% 
Color2 ..........................................................................white to light cream/natural color 
Flavor2 ................................................................................... clean and pleasing 
Ingredient Statement 
“Nonfat Dry Milk” (_____________ % milkfat) if the fat content is over 1.5% 
Production Applications and Functionality 
Fluid milk fortification, frozen desserts, cheese, yogurt, dairy beverages, bakery products, 
custards, gravies, sauces, frozen foods, packaged dry mixes, processed meats, soups, infant 
formulas, snack foods, cosmetics Nonfat dry milk is classified for end-product use according to 
the heat-treatment used in its manufacture. 
The classifications are: high-heat, medium-heat and low-heat. (see page 2) 
Storage & Shipping 
Product should be stored and shipped in a cool, dry environment with temperatures below 80F 
and relative humidities below 65%. Stocks should be rotated and utilized within 1 to 1 ½ years. 
Packaging 
Multiwall kraft bags with polyethylene inner liner or other approved closed container. 
(i.e. “tote bins,” etc) 
Typical Compositional Range1 
Percentage 
Protein.................................34.0 – 37.0 
Lactose................................49.5 – 52.0 
Fat2 ........................................0.6 – 1.25 
Ash..........................................8.2 – 8.6 
Moisture2.................................3.0 – 4.0 
Microbiological Analysis 
Standard Plate Count2 ............... < 10,000/g 
Coliform2 ......................................... < 10/g 
Salmonella .................................... negative 
Listeria .......................................... negative 
Coagulase-positive 
Staphylococci............................. negative 
_____________________________________ 
1 On an “as is” basis 
2 USDA Grade parameters (7 CFR §58.2528) 
- 1 - 
Specification 5: Non Fat Dry Milk 
Sp
 
ecification 6: W
 
 
 
 
hey Protein Concentrate 
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MPP Compositional and Microbial Specification Sheet  
Analysis Tolerance- Range  Actual  
Moisture  35-40%  
Fat  23-27%  
Protein 20-27%  
Coliform  < 10 CFU/ml  
E-coli  < 10000 CFU/ml  
SPC < 20000 CFU/ml  
Specification 7: Milk Protein Precipitate (MPP)  
 
 
 
 
 
 
113
Flavor profile Analysis  
Table 7-1: Bench-top flavor experiments, both sweet and savory. 
Date  Company  Flavor ID Flavor  Process Notes  
5/4/10  Gold 
Coast  
336755 
336957 
332912 
Cranberry  Baked  Low detection, low sweetness 
Better flavor, berry like. 
Strong flavor, almost plastic like  
11/6/09 Kraft 
 
 
21000139800 
210007087900 
21004003600 
210000110600 
21007084200 
210006935800 
Cheese 
10% use level 
Freeze Dried  + pretty cheesy. 
+ bitterness, cheesiness.                           
- musty or rancid, 
 - less cheese, 
- pizza-like flavor, Italian spices.  
+ cheesy but mild. 
9/29/10 Firmenich 057637  
059200 AP0551  
Vanilla  
Artificial 
Cream+ Vanilla  
Freeze Dried  Low flavor, poor coverage.  
Better coverage needs higher vanilla. 
9/22/10 Firmenich 057622 TP0551  
588734 SPM  
557075 SPM  
  Chicken  Freeze Dried  Bad, heavy roast, unpleasant.   
Non descript, high salt. 
To sweet, no flavor. 
9/15/09 Firmenich 868519CB + 
885023 TTB0440 
Pizza  
Roast Garlic  
Freeze Dried  Good flavor, garlic slightly too high, 
good cracker-like 
Fi
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Table 7-2: Outliers for each marker occurring by week and team, outlier defined as >/< 2stds. 
  Subject ID  
Response Team Week 1 Week 2 
A – Cort  Gold 37 35 
Green  7  
Adolose Gold 12, 21 6 
Green  11, 24, 3, 2 3 
CPK Gold 12, 21 12, 25 
Green  2, 3, 20, 24,11 3 
CRP Gold 17  
Green  8 29, 7 
EPO Gold  28 
Green   4 
 
Table 7-3: Effect of test period on blood marker, separated by team and week. 
Marker Team Week 1 Week 2 
EPO Gold No Change  Increase 
 Green Increase  Increase 
Cortisol  Gold Increase  Decrease 
 Green Decrease Decrease 
CRP Gold Increase Increase 
 Green Decrease Increase 
CPK Gold Increase Increase  
 Green Decrease Increase 
Adolase  Gold Increase Increase 
 Green Increase  Decrease 
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Compositional and Microbial results for MPP and Test RTE Bars  
Table 7-4: Microbial and Compositional specifications for MPP product  
 
 
 
 
Test 1a 5/13/10 Date Read 10-1 10-2 
E- Coli - CC 5/15/10 0 0 0 0 
Coliform  5/16/10 1 0 0 0 
SPC 5/16/10 21 24 0 0 
Yeast/Mold  5/17-5/24 0 0 0 0 
  
Test 2a 5/28/10 Date Read 10-1 10-2 
E- Coli - CC 5/29/10 – 5/30/10 0          0 0         0 0           0 0          0 
Coliform  5/30/10 1        6 1         4 0          0 0          0 
SPC 5/30/10 78 81 2 4 
Yeast/Mold  5/30-6/25 0 0 0 0 
 
Specification Tolerance- Range  1a 5/13/10 2a 5/28/10 
Moisture  35-40% 36.9% 36.6% 40.2% 43.3% 
Fat  23-27% 22.9% 28% 
Protein 20-27% 20.95% 27% 
 
Table 7-5: Compositional specifications for RTE bars product 
Spec Tolerance- Range  1a1 1a2 1a3 1a4 
Moisture  >24% 27.22 26.22 25.66 25.66 
aW  >0.890 0.91 0.91 0.89 0.89 
Protein <29% 33.1 32.0 31.7 32.2 
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Spec Tolerance- Range  2a1 2a2 2a3 2a4 
Moisture  >24% 24.4 24.0 23.3 23.8 
aW  >0.890 0.885 0.896 0.894 0.888 
Protein <29% 33 38 33.6 32.6 
 
Table 7-6: Microbial specifications for RTE bars product 
 
Test plated 1a1 1a2 1a3 1a4 
E- Coli - CC 10-1 0          0 0          0 0          0 0          0 
Read 6/2/10 10-2 0          0 0          0 0          0 0          0 
Coliform 10-1 0          0 0          0 0          0 0          0 
Read 6/2/10 10-2 0          0 0          0 0          0 0          0 
SPC 10-1 0          2 2          3 3          0 4          5 
Read 6/2/10 10-2 0          1 0          1 0          0 0          0 
Yeast/Mold 10-1 0          0 0          0 0          0 0          0 
Read 6/3-6/25/10     
 
Test plated 2a1 2a2 2a3 2a4 
E- Coli - CC 10-1 0          0 0          0 0          0 0          0 
Read 5/18/10 10-2 0          0 0          0 0          0 0          0 
Coliform 10-1 0          0 0          0 0          0 0          0 
Read 5/19/10 10-2 0          0 0          0 0          0 0          0 
SPC 10-1 0          3 0          0 1          1 1          0 
Read 5/19/10 10-2 0          0 2          0 0          1 0          1 
Yeast/Mold 10-1 0          0 0          0 0          0 0          0 
Read 5/24/10     
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Blood Marker and Compositional Data 
CDC/AHA recommended cut of points <1.0 low  , >3.0 High   
ID   5/21/10  5/24/10  Delta 6/4/10 6/7/10 Delta Sum Estimate  
Gold                  
27  0.4  1.8  1.4 2.7 1.2 ‐1.5 ‐0.1 1.45 
12  0.4  1.8  1.4 0.4 0.8 0.4 1.8 0.5 
16  0.6  1.5  0.9 0.6 1 0.4 1.3 0.25 
32  0.5  1.4  0.9 0.5 0.7 0.2 1.1 0.35 
31  1  2.3  1.3 0.5 1.1 0.6 1.9 0.35 
37  16.8  17.7  0.9 2.5 11.5 9 9.9 ‐4.05 
25  2.1  3.2  1.1 0.5 1.2 0.7 1.8 0.2 
30  0.4  1  0.6 3.7 4.2 0.5 1.1 0.05 
6  0.5  0.9  0.4 1.2 0.8 ‐0.4 0.00 0.4 
36  0.7  1.6  0.9 0.5 0.7 0.2 1.1 0.35 
4  1.9  1.5  ‐0.4 0.8 1.1 0.3 ‐0.1 ‐0.35 
1  0.5  2.4  1.9 0.5 1.1 0.6 2.5 0.65 
17  2.2  5  2.8 2.7 4 1.3 4.1 0.75 
38  0.6  1.6  1 2 1.7 ‐0.3 0.7 0.65 
35  0.5  0.8  0.3 0.5 0.5 0 0.3 0.15 
21  2.2  4.2  2 0.6 1.3 0.7 2.7 0.65 
13  0.9  1.3  0.4 0.5 0.7 0.2 0.6 0.1 
                 
Green                
18  0.4  1  0.6 0.4 1.1 0.7 1.3 ‐0.05 
2  0.3  0.6  0.3 0.3 0.9 0.6 0.9 ‐0.15 
34  0.6  0.7  0.1 0.4 1 0.6 0.7 ‐0.25 
7  1.7  0.9  ‐0.8 3.9 8.2 4.3 3.5 ‐2.55 
23  0.3  4.5  4.2 0.4 0.7 0.3 4.5 1.95 
5  0.3  1.4  1.1 0.3 0.7 0.4 1.5 0.35 
8  34.8  11.6  ‐23.2 2.8 3.3 0.5 ‐22.7 ‐11.85 
3  0.4  0.6  0.2 0.6 2.3 1.7 1.9 ‐0.75 
9  0.4  0.9  0.5 0.5 0.6 0.1 0.6 0.2 
20  0.5  0.9  0.4 0.8 1.8 1 1.4 ‐0.3 
28  0.3  0.6  0.3 0.4 2 1.6 1.9 ‐0.65 
29  1.3  5.6  4.3 2.3 4.7 2.4 6.7 0.95 
39  0.9  0.9  0 1.8 0.9 ‐0.9 ‐0.9 0.45 
24  0.9  2  1.1 0.9 1.5 0.6 1.7 0.25 
11  0.5  0.9  0.4 0.5 1.6 1.1 1.5 ‐0.35 
19  0.3  1.3  1 0.3 1.1 0.8 1.8 0.1 
26  0.4  1.7  1.3 0.5 0.7 0.2 1.5 0.55 
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ID   5/21/10  5/24/10 Delta 6/4/10 6/7/10 Delta Sum  Estimate 
Gold                  
27  15.3  10.6 ‐4.7 15.7 18.4 2.7  ‐2  ‐3.7
12  16.6  10.5 ‐6.1 18.6 14 ‐4.6  ‐10.7  ‐0.75
16  17.1  12.3 ‐4.8 10.5 16.1 5.6  0.8  ‐5.2
32  20.8  24.4 3.6 29.4 24.4 ‐5  ‐1.4  4.3
31  17.4  19.5 2.1 11.1 8.7 ‐2.4  ‐0.3  2.25
37  9.1  28.2 19.1 14.1 9.5 ‐4.6  14.5  11.85
25  12.8  7.8 ‐5 23 19.1 ‐3.9  ‐8.9  ‐0.55
30  9.4  22.4 13 19.2 10.5 ‐8.7  4.3  10.85
6  11.6  19.4 7.8 9.6 9.3 ‐0.3  7.5  4.05
36  30.5  39.8 9.3 22.7 23.3 0.6  9.9  4.35
4  18.4  15.7 ‐2.7 17.9 11.2 ‐6.7  ‐9.4  2
1  17.4  24.8 7.4 21.1 23.4 2.3  9.7  2.55
17  8.8  12.1 3.3 9.1 15.8 6.7  10  ‐1.7
38  19.5  24.8 5.3 20 20.6 0.6  5.9  2.35
35  11.5  14.8 3.3 8.2 20.7 12.5  15.8  ‐4.6
21  2.6  12.6 10 19.4 21.4 2  12  4
13  18.5  13 ‐5.5 15.2 11.6 ‐3.6  ‐9.1  ‐0.95
                 
Green                 
18  16.9  11.5 ‐5.4 13.7 9 ‐4.7  ‐10.1  ‐0.35
2  13  15.7 2.7 20.7 18.8 ‐1.9  0.8  2.3
34  18.9  20.4 1.5 18.2 13.2 ‐5  ‐3.5  3.25
7  23  10.7 ‐12.3 13 14.1 1.1  ‐11.2  ‐6.7
23  12.7  17.6 4.9 13.8 10.7 ‐3.1  1.8  4
5  22.8  16.7 ‐6.1 10.1 17.9 7.8  1.7  ‐6.95
8  20.2  19.3 ‐0.9 23.2 15.2 ‐8  ‐8.9  3.55
3  10.5  15.5 5 12.8 17.5 4.7  9.7  0.15
9  20.3  24 3.7 14.4 14.8 0.4  4.1  1.65
20  12  14 2 18.6 14.2 ‐4.4  ‐2.4  3.2
28  17.7  23.4 5.7 26.5 21.5 ‐5  0.7  5.35
29  22.9  18.5 ‐4.4 19.8 18.2 ‐1.6  ‐6  ‐1.4
39  17.3  18.4 1.1 13.2 13 ‐0.2  0.9  0.65
24  18.8  14.3 ‐4.5 14.1 11.3 ‐2.8  ‐7.3  ‐0.85
19  15.6  13.5 ‐2.1 14.5 19.7 5.2  3.1  ‐3.65
11  22.3  17.6 ‐4.7 15.5 21.3 5.8  1.1  ‐5.25
26  22.7  16.5 ‐6.2 18.3 21.8 3.5  ‐2.7  ‐4.85
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Albolase range 1.5 ‐ 8.1, U/L             
ID   5/21/10  5/24/10 Delta 6/4/10 6/7/10 Delta Sum  Estimate 
Gold                 
27  5.3  7.8 2.5 4.1 5.4 1.3  3.8  0.6
12  8.2  21 12.8 6.2 9.5 3.3  16.1  4.75
16  7.2  8.8 1.6 2.8 4.8 2  3.6  ‐0.2
32  4  5.6 1.6 3.3 3.8 0.5  2.1  0.55
31  6.1  8.7 2.6 3.1 5.8 2.7  5.3  ‐0.05
37  6.8  11.3 4.5 4.1 5.2 1.1  5.6  1.7
25  7.6  15.7 8.1 4.8 6 1.2  9.3  3.45
30  5.2  6.7 1.5 3.2 3.5 0.3  1.8  0.6
6  8.6  11 2.4 10.2 5.8 ‐4.4  ‐2  3.4
36  4.1  5.1 1 3 2.7 ‐0.3  0.7  0.65
4  7.8  13.5 5.7 5.2 6.3 1.1  6.8  2.3
1  5.5  13.7 8.2 6.8 7.1 0.3  8.5  3.95
17  6.1  8.2 2.1 3.8 5.8 2  4.1  0.05
38  7.5  8.4 0.9 3.5 5.7 2.2  3.1  ‐0.65
35  3.1  9.3 6.2 4.6 4 ‐0.6  5.6  3.4
21  6.8  23.7 16.9 9 6.6 ‐2.4  14.5  9.65
13  8.1  12.9 4.8 5.6 7.5 1.9  6.7  1.45
                 
Green                 
18  5.5  10.1 4.6 4 5.8 1.8  6.4  1.4
2  3.8  9.9 6.1 3.3 5.8 2.5  8.6  1.8
34  11.9  11.3 ‐0.6 3.8 4 0.2  ‐0.4  ‐0.4
7  6.9  7.6 0.7 5.1 5.6 0.5  1.2  0.1
23  4.7  10.1 5.4 4.4 4.2 ‐0.2  5.2  2.8
5  6.6  8.5 1.9 3.8 5.3 1.5  3.4  0.2
8  7.1  7.5 0.4 11.5 5.4 ‐6.1  ‐5.7  3.25
3  11.7  17.6 5.9 27.1 11.4 ‐15.7  ‐9.8  10.8
9  9.2  10.7 1.5 10.6 5.8 ‐4.8  ‐3.3  3.15
20  4.8  9.5 4.7 3.4 5.1 1.7  6.4  1.5
28  7  6.7 ‐0.3 4 4.2 0.2  ‐0.1  ‐0.25
29  6.8  8.7 1.9 6.4 4.7 ‐1.7  0.2  1.8
39  5.2  7.7 2.5 4.6 5.2 0.6  3.1  0.95
24  6.1  13.6 7.5 4.6 5.5 0.9  8.4  3.3
19  5.3  8.7 3.4 4.8 6.7 1.9  5.3  0.75
11  6.5  15.4 8.9 5.8 6.5 0.7  9.6  4.1
26  6.2  9.4 3.2 4.6 4.6 0  3.2  1.6
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Creatine Kinase (CPK total), Range 35 ‐ 104, U/L        
ID   5/21/10  5/24/10 Delta 6/4/10 6/7/10 Delta Sum  Estimate 
Gold                 
27  94  571 477 85 205 120  597  178.5
12  518  3815 3297 605 1372 767  4064  1265
16  270  564 294 98 154 56  350  119
32  77  285 208 105 177 72  280  68
31  151  507 356 123 152 29  385  163.5
37  127  895 768 95 207 112  880  328
25  580  1935 1355 275 698 423  1778  466
30  117  279 162 90 141 51  213  55.5
6  694  923 229 686 496 ‐190  39  209.5
36  127  256 129 106 134 28  157  50.5
4  260  1402 1142 207 385 178  1320  482
1  363  1573 1210 375 672 297  1507  456.5
17  198  351 153 114 190 76  229  38.5
38  283  684 401 91 409 318  719  41.5
35  134  557 423 106 173 67  490  178
21  279  3781 3502 243 472 229  3731  1636.5
13  324  812 488 127 315 188  676  150
                 
Green                  
18  121  667 546 118 260 142  688  202
2  125  828 703 122 527 405  1108  149
34  433  412 ‐21 101 129 28  7  ‐24.5
7  120  407 287 152 128 ‐24  263  155.5
23  95  263 168 106 155 49  217  59.5
5  163  219 56 53 153 100  156  ‐22
8  73  156 83 160 152 ‐8  75  45.5
3  597  1400 803 1916 749 ‐1167  ‐364  985
9  413  501 88 465 161 ‐304  ‐216  196
20  201  1090 889 162 352 190  1079  349.5
28  365  449 84 289 213 ‐76  8  80
29  123  401 278 110 207 97  375  90.5
39  65  181 116 85 118 33  149  41.5
24  258  981 723 144 339 195  918  264
11  176  1099 923 221 224 3  926  460
19  86  391 305 113 203 90  395  107.5
26  367  989 622 346 353 7  629  307.5
 
 
 
 
124
Eruthtopoietin Range 4 ‐ 27 mU/mL.           
ID   5/21/10  5/24/10 Delta 6/4/10 6/7/10 Delta Sum  Estimate 
Gold                  
27  6  6 0 4 6 2  2  ‐1
12  6  9 3 8 7 ‐1  2  2
16  6  4 ‐2 5 5 0  ‐2  ‐1
32  9  5 ‐4 7 4 ‐3  ‐7  ‐0.5
31  13  7 ‐6 9 9 0  ‐6  ‐3
37  14  13 ‐1 10 14 4  3  ‐2.5
25  10  17 7 15 18 3  10  2
30  7  7 0 8 10 2  2  ‐1
6  7  7 0 11 6 ‐5  ‐5  2.5
36  10  5 ‐5 6 9 3  ‐2  ‐4
4  13  14 1 8 19 11  12  ‐5
1  9  4 ‐5 8 11 3  ‐2  ‐4
17  8  11 3 9 8 ‐1  2  2
38  4  5 1 4 7 3  4  ‐1
35  6  7 1 6 9 3  4  ‐1
21  7  6 ‐1 6 9 3  2  ‐2
13  7  7 0 7 10 3  3  ‐1.5
                 
Green                  
18  7  11 4 8 15 7  11  ‐1.5
2  9  7 ‐2 11 13 2  0  ‐2
34  5  7 2 6 7 1  3  0.5
7  9  6 ‐3 5 7 2  ‐1  ‐2.5
23  6  8 2 8 6 ‐2  0  2
5  5  6 1 5 6 1  2  0
8  8  5 ‐3 4 7 3  0  ‐3
3  9  11 2 13 10 ‐3  ‐1  2.5
9  7  6 ‐1 6 7 1  0  ‐1
20  3  8 5 12 9 ‐3  2  4
28  10  8 ‐2 13 5 ‐8  ‐10  3
29  6  4 ‐2 6 5 ‐1  ‐3  ‐0.5
39  11  9 ‐2 15 22 7  5  ‐4.5
24  3  5 2 5 5 0  2  1
19  5  6 1 4 8 4  5  ‐1.5
11  10  13 3 9 9 0  3  1.5
26  10  14 4 8 8 0  4  2
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ID  
Wk1 Wt 
Change  
Wk1 % Fat 
Change
Wk 2 Wt 
Change 
Wk2 C % Fat 
Change 
Gold          
27  0  0.69 0 0.69 
12  ‐1  ‐10.15 7 ‐10.15 
16  ‐4  ‐3.9 ‐5 ‐3.9 
32  ‐2  6.05 ‐3.5 6.05 
31  ‐2.5  ‐0.06 ‐2 ‐0.06 
37  1  0.66 0.5 0.66 
25  ‐1  ‐2.45 ‐3 ‐2.45 
30  4  ‐1.13 1 ‐1.13 
6  ‐2  ‐4.75 ‐8 ‐4.75 
36  1  ‐6.26 0.5 ‐6.26 
4  ‐3  ‐2.32 ‐1 ‐2.32 
1  ‐1  ‐1.15 ‐3 ‐1.15 
17  3  ‐0.42 ‐3 ‐0.42 
38  ‐3  ‐0.67 ‐4 ‐0.67 
35  ‐1  ‐0.48 0 ‐0.48 
21  ‐3  0.5 ‐8 0.5 
13  3  ‐0.36 1.5 ‐0.36 
         
Green         
18  ‐2  0.94 ‐1 0.94 
2  1  0.01 2 0.01 
34  1  ‐2.87 0 ‐2.87 
7  0  ‐1.36 ‐3 ‐1.36 
23  2  0.01 1 0.01 
5  2  ‐9.35 3 ‐9.35 
8  0  ‐1.29 ‐2 ‐1.29 
3  2  ‐1.72 1 ‐1.72 
9  ‐3  ‐0.78 ‐3 ‐0.78 
20  0  ‐4.87 ‐1 ‐4.87 
28  2  ‐0.83 ‐4.5 ‐0.83 
29  0  ‐1.16 ‐2 ‐1.16 
39  1  ‐5.17 0.5 ‐5.17 
24  2  0.2 1 0.2 
19  3  ‐0.8 ‐4 ‐0.8 
11  5  ‐0.82 ‐0.5 ‐0.82 
26  1  0.21 1.5 0.21 
 
